{"id": "batch_req_68195a787b7c8190924b97c30fa056a4", "custom_id": "Candesartan-Citalopram-Fluphenazine-Histamine H1 receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "3191818e7fe41c02bcf057d55164e569", "body": {"id": "chatcmpl-BTyjAtKofdf66gLmJKUskwenWhruW", "object": "chat.completion", "created": 1746484648, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described antipsychotic is fluphenazine, a high-affinity phenothiazine that, in addition to dopamine receptors, binds and inhibits the Histamine H1 receptor\u2014a rhodopsin-like GPCR that signals via Gq to activate phospholipase C/IP3.  \nANSWER: Histamine H1 receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1251, "completion_tokens": 284, "total_tokens": 1535, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a789468819081ba0c666b72385e", "custom_id": "Lamotrigine-Oxaprozin-Sildenafil_4:upper_bound", "response": {"status_code": 200, "request_id": "0b9c738d90a07144e94a9e7f28d438cf", "body": {"id": "chatcmpl-BTyjERzxudclic7gzSmM9GKEwZTr1", "object": "chat.completion", "created": 1746484652, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug featuring a pyrazolopyrimidinone core with an N-ethylpiperazine sulfonamide side chain that engages in \u03c0-\u03c0 stacking with Oxaprozin is Sildenafil. Oxaprozin in turn hydrogen-bonds with Lamotrigine, the dichlorophenyl triazine derivative, linking Sildenafil indirectly to Lamotrigine.  \nANSWER: Sildenafil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 454, "completion_tokens": 291, "total_tokens": 745, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a78b11481909eab1c374fc6508f", "custom_id": "Ranitidine-Sibutramine-Zolpidem_4:upper_bound", "response": {"status_code": 200, "request_id": "5556454d7de7053ff3ab41544ea206f9", "body": {"id": "chatcmpl-BTyjJ7bdqIe4mZT6Jb2iFc0G1wLZQ", "object": "chat.completion", "created": 1746484657, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The imidazopyridine core substituted with a methyl and a benzyl group describes Zolpidem. The background data indicates that Sibutramine, which contains a cyclobutyl ring and a 4-chlorophenyl group, engages in \u03c0-\u03c0 stacking interactions with Zolpidem.  \nANSWER: Zolpidem", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 422, "completion_tokens": 413, "total_tokens": 835, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a78c4d48190bbb7f6d9364102b4", "custom_id": "Cetirizine-Dipyridamole-Sildenafil-Zaleplon_2:upper_bound", "response": {"status_code": 200, "request_id": "fd0c9f818da97ec9bee0721b7edceac5", "body": {"id": "chatcmpl-BTyjPFW1fjqrCFF53ZRGQ9l6VvX1D", "object": "chat.completion", "created": 1746484663, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes sildenafil (a selective PDE5 inhibitor) and its interaction with a nonbenzodiazepine pyrazolopyrimidine sedative-hypnotic used for insomnia. The provided interaction triple \u201cSildenafil-apoplexy-Zaleplon\u201d identifies Zaleplon as the co-administered drug that leads to apoplexy when taken with sildenafil.  \nANSWER: Zaleplon", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1025, "completion_tokens": 491, "total_tokens": 1516, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a78e4108190aa18544931ba8878", "custom_id": "Alprazolam-Bumetanide-Fenofibrate-Modafinil_5:upper_bound", "response": {"status_code": 200, "request_id": "6205a48d5439560b5787c3e9a861dc6d", "body": {"id": "chatcmpl-BTyjZqxjlrxcFWw1nWbzzdkXgDMvJ", "object": "chat.completion", "created": 1746484673, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described sulfinyl-linked diphenylmethane core with an acetamide side chain matches the structure of Modafinil (C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N). According to the interaction data, Modafinil engages in aromatic \u03c0-\u03c0 stacking with Fenofibrate, a fibrate derivative bearing isopropyl and phenoxy groups.  \nANSWER: Modafinil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 519, "completion_tokens": 505, "total_tokens": 1024, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a78f6c481909cc1c6d97f1f893f", "custom_id": "alendronic acid-Pyridostigmine_0:upper_bound", "response": {"status_code": 200, "request_id": "62f11c37e36c68767e8ad4d9170ce150", "body": {"id": "chatcmpl-BU0e2TgPD8GqfL8cyS5OTXFjmLviR", "object": "chat.completion", "created": 1746492018, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple alendronic acid\u2013gastric inflammation\u2013pyridostigmine indicates that alendronic acid (the bisphosphonate) carries the increased risk of gastric inflammation when given with pyridostigmine.  \nANSWER: alendronic acid", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 698, "completion_tokens": 204, "total_tokens": 902, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7910e48190a2ec517fe3cac8f1", "custom_id": "Ketorolac-Oxaprozin_0:upper_bound", "response": {"status_code": 200, "request_id": "9677c7b0ae9adeef2847f0697c69df94", "body": {"id": "chatcmpl-BTyjDp4JKWZXk8YQT57uqem4YsAzZ", "object": "chat.completion", "created": 1746484651, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a drug indicated for moderate to severe nociceptive pain that potently inhibits prostaglandin synthesis and, when combined with a propionic acid\u2013derived NSAID (oxaprozin), can exacerbate gastric inflammation. That profile matches ketorolac, a potent COX-1/COX-2 inhibitor used for short-term pain relief but associated with gastrointestinal adverse effects.  \nANSWER: Ketorolac", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 672, "completion_tokens": 300, "total_tokens": 972, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7922448190a84a23b9ab0b6a6e", "custom_id": "Naproxen-Doxazosin-Alpha-1B adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "532984afbb06ecd4573f97364459b260", "body": {"id": "chatcmpl-BU0e2Gu6bx26mgsfdMD3xA4XxCDK9", "object": "chat.completion", "created": 1746492018, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Doxazosin is a quinazoline-class selective \u03b11-adrenergic blocker whose efficacy stems from binding to and inhibiting the \u03b11B-adrenergic receptor. Structural studies have resolved this receptor in complex with the inverse agonist (+)-cyclazosin, confirming it as doxazosin\u2019s direct target.  \n\nANSWER: Alpha-1B adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 865, "completion_tokens": 356, "total_tokens": 1221, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a79321c819081f959d21e8a0536", "custom_id": "Chloroquine-hydroxychloroquine_3:upper_bound", "response": {"status_code": 200, "request_id": "cdf0696c439eaed66ee2ecd83ec66783", "body": {"id": "chatcmpl-BU0e288PT20IJ7VyyPL6hlxnnK9s2", "object": "chat.completion", "created": 1746492018, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The molecule with the terminal ethanol (\u2013CH2CH2OH) on its ethylamino side chain has an extra hydroxyl group capable of acting as both a hydrogen\u2010bond donor and acceptor. This additional \u2013OH is absent in the other compound, so the hydroxyl\u2010containing molecule can form more hydrogen bonds.  \r\nANSWER: hydroxychloroquine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 350, "completion_tokens": 288, "total_tokens": 638, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7951ac81909938338642536ffc", "custom_id": "Amlodipine-Pamidronic acid-thiotepa_1:upper_bound", "response": {"status_code": 200, "request_id": "e950a88938b12f78c63122e68e332918", "body": {"id": "chatcmpl-BTyjDlfLMQ0pmTh6NvJyqHRQub28Q", "object": "chat.completion", "created": 1746484651, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The bisphosphonate causing erythema with both amlodipine and the anti-cancer agent is pamidronic acid. The organophosphorus anti-cancer medication interacting with pamidronic acid to produce erythema is thiotepa.  \nANSWER: thiotepa", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 637, "completion_tokens": 144, "total_tokens": 781, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 64, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a796c4c81909e11ed0b8b6ae91a", "custom_id": "Diazepam-Duloxetine-Acamprosate_4:upper_bound", "response": {"status_code": 200, "request_id": "b44824844f99850ed64418ebaa2b4e55", "body": {"id": "chatcmpl-BTyjD8HU8h4hn82yqKMIWHlcGwAgy", "object": "chat.completion", "created": 1746484651, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The description \u201cacetyl amide and a sulfonic acid functional group attached to a three-carbon chain\u201d matches Acamprosate (SMILES CC(=O)NCCCS(=O)(=O)O). According to the provided interaction triples, Acamprosate forms a hydrogen bond with Duloxetine, which contains a thiophene ring linked via an ether to a naphthyl moiety.  \nANSWER: Acamprosate", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 398, "completion_tokens": 628, "total_tokens": 1026, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7983948190be750479c112a912", "custom_id": "Tramadol-Exemestane_0:upper_bound", "response": {"status_code": 200, "request_id": "5e06b2fce6f7e14f480226b72b2fa038", "body": {"id": "chatcmpl-BTyjDYaqK12gnnieVNEcPhlWZ0o5l", "object": "chat.completion", "created": 1746484651, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Exemestane is the aromatase inhibitor used for hormone-receptor\u2013positive breast cancer, and the reported drug\u2013drug interaction triple \u201cTramadol\u2013pneumonia\u2013Exemestane\u201d indicates that tramadol co\u2010administered with exemestane is associated with a potential risk of pneumonia.  \nANSWER: Tramadol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 597, "completion_tokens": 349, "total_tokens": 946, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a79a52881908fb80838249aa733", "custom_id": "Haloperidol-Muscarinic acetylcholine receptor M5_6:upper_bound", "response": {"status_code": 200, "request_id": "70dd9d17c70aca82b7f49ab2d5de96e9", "body": {"id": "chatcmpl-BTyjH2xhijprCnXYGpCYBg9VI2muE", "object": "chat.completion", "created": 1746484655, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Haloperidol is a butyrophenone antipsychotic that binds to and inhibits the muscarinic acetylcholine receptor M5, a G protein\u2013coupled receptor whose activation by acetylcholine inhibits adenylate cyclase and lowers PKA activity.  \nANSWER: Muscarinic acetylcholine receptor M5", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 681, "completion_tokens": 281, "total_tokens": 962, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a79beb88190bc3f842b1e9425cc", "custom_id": "Alprazolam-Ciclopirox_3:upper_bound", "response": {"status_code": 200, "request_id": "c2827ecea7a1d1ed0b1893a0978f3a9f", "body": {"id": "chatcmpl-BTyjLzWx5cHe5RcKDsnLrBMPuJicF", "object": "chat.completion", "created": 1746484659, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The triazolobenzodiazepine core fused to a chlorinated aromatic ring describes Alprazolam, which contains several nitrogen atoms (in the diazepine and triazole rings) capable of acting as hydrogen-bond acceptors (and the diazepine N\u2013H can act as a donor).  \nANSWER: Alprazolam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 342, "completion_tokens": 477, "total_tokens": 819, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a79d6a48190b9c794f6ec0c8f77", "custom_id": "Norfloxacin-Zolpidem-vincristine-Torasemide_2:upper_bound", "response": {"status_code": 200, "request_id": "f53388758715d04a43bea8067b074194", "body": {"id": "chatcmpl-BTyjYiXi6ZlrCZoxzPQRh0Y8l3aWq", "object": "chat.completion", "created": 1746484672, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The antineoplastic agent described is vincristine (a Catharanthus-derived mitotic inhibitor with prominent neurotoxicity). The loop diuretic on the WHO essential medicines list used for fluid overload is torasemide. According to the provided interaction TRIPLE (\u201cvincristine-drug toxicity NOS-Torasemide\u201d), torasemide administration increases vincristine toxicity.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1273, "completion_tokens": 297, "total_tokens": 1570, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a79e56c81908e39756bc56d0b8f", "custom_id": "Naproxen-Ondansetron-Salmeterol-Beta-1 adrenergic receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "4bc7d2eb362db723ba48a1ada972f38d", "body": {"id": "chatcmpl-BTyjZhUdA76Lo7PepidnqSAkHeWox", "object": "chat.completion", "created": 1746484673, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The long-acting inhaled bronchodilator is Salmeterol, which in addition to its \u03b22 activity can bind and activate the \u03b21 adrenergic receptor\u2014a GPCR predominantly in cardiac tissue and also in the cerebral cortex.  \nANSWER: Beta-1 adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1184, "completion_tokens": 335, "total_tokens": 1519, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a79f7008190befa5b6cbffbb6e2", "custom_id": "Cetirizine-Temozolomide_0:upper_bound", "response": {"status_code": 200, "request_id": "a80c0b4e6e516940c3ee4afabd5dcae6", "body": {"id": "chatcmpl-BTyjZ0tvwymMtb60bpHHPcPRF6i1L", "object": "chat.completion", "created": 1746484673, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple specifies that cetirizine, a second-generation H1-antihistamine used for allergic conditions and noted for its relatively low sedation among its class, is linked to erythema when co-administered with the alkylating agent temozolomide.\n\nANSWER: Cetirizine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 729, "completion_tokens": 536, "total_tokens": 1265, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a0ef88190888c025f6aa28728", "custom_id": "Ziprasidone-Acamprosate_3:upper_bound", "response": {"status_code": 200, "request_id": "dcc1cc44b24e24cd1b33f990c150c069", "body": {"id": "chatcmpl-BTyjfSBqa0XtyLZInL3Xljl8GKhNs", "object": "chat.completion", "created": 1746484679, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The indolinone/benzothiazole scaffold in ziprasidone presents a carbonyl oxygen and heterocyclic nitrogens that serve as hydrogen-bond acceptors. In contrast, acamprosate\u2019s sulfonic acid OH (and its amide N\u2013H) can donate hydrogen bonds to those acceptor sites.  \nANSWER: Ziprasidone acts as the hydrogen-bond acceptor; acamprosate acts as the hydrogen-bond donor.", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 340, "completion_tokens": 1334, "total_tokens": 1674, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1216, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a1c8c8190ae578d7fa9a64223", "custom_id": "Orphenadrine-Sumatriptan_0:upper_bound", "response": {"status_code": 200, "request_id": "8a69927a38b81447da6fed89f14fa168", "body": {"id": "chatcmpl-BTyjgJl16LoBbraQ8hmda0eGfYN8G", "object": "chat.completion", "created": 1746484680, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction data lists an erythema adverse reaction for the combination Orphenadrine\u2013Sumatriptan. Sumatriptan is the selective 5-HT1B/1D agonist used for acute migraine attacks, so the co-administered drug linked to erythema is Orphenadrine.  \nANSWER: Orphenadrine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 606, "completion_tokens": 479, "total_tokens": 1085, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a2ed88190a2bb2c4b046e1488", "custom_id": "Triazolam-Rosiglitazone-Bimatoprost_1:upper_bound", "response": {"status_code": 200, "request_id": "4815ad748a877fcc88a11f28a81e81a9", "body": {"id": "chatcmpl-BTyjgv2WUum2Q0ws6kWoxmUNcHyRD", "object": "chat.completion", "created": 1746484680, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The thiazolidinedione PPAR\u03b3 agonist is rosiglitazone (drug 2). The ophthalmic agent that lowers intraocular pressure and enhances eyelash growth is bimatoprost (drug 3). The provided interaction triple \u201cRosiglitazone\u2013Adenopathy\u2013Bimatoprost\u201d indicates that adenopathy is a risk when these two are co-administered.  \nANSWER: Bimatoprost", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 929, "completion_tokens": 368, "total_tokens": 1297, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a49048190aa53779d74ec5786", "custom_id": "Furosemide-melphalan_0:upper_bound", "response": {"status_code": 200, "request_id": "09e0a303439691d155a6b6b060bf697c", "body": {"id": "chatcmpl-BTyjoCMffyuvO6fWMzQlx0WrnQxfj", "object": "chat.completion", "created": 1746484688, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The documented interaction triple \u201cFurosemide\u2013Dyspnea exertional\u2013Melphalan\u201d indicates that when Furosemide is combined with Melphalan, exertional dyspnea is the observed adverse effect.  \nANSWER: Furosemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 737, "completion_tokens": 1098, "total_tokens": 1835, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1024, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a66ec8190a4bb9c6a75b89b03", "custom_id": "Fentanyl-desvenlafaxine_0:upper_bound", "response": {"status_code": 200, "request_id": "aa1c0b2dc958d0a09f8f851b775124c6", "body": {"id": "chatcmpl-BTyjod6sMq5RDLiKItflTGWWwSQOj", "object": "chat.completion", "created": 1746484688, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple \u201cFentanyl\u2013nervous tension\u2013desvenlafaxine\u201d indicates that when the highly potent opioid fentanyl is coadministered with an SNRI antidepressant associated with central nervous system excitation (e.g., agitation, nervous tension), the latter drug contributes to the nervous tension effect. Desvenlafaxine\u2019s known adverse profile includes autonomic and neuropsychiatric symptoms such as nervous tension, fitting this interaction.  \nANSWER: desvenlafaxine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 746, "completion_tokens": 442, "total_tokens": 1188, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a7edc819086acbc34084bfee4", "custom_id": "Alprazolam-Ciclopirox_0:upper_bound", "response": {"status_code": 200, "request_id": "9dbb18c99b256c47a086f1a53c49e078", "body": {"id": "chatcmpl-BTyjqhYjd8uM61KIGMsECXlknj8S9", "object": "chat.completion", "created": 1746484690, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described drug is a high-affinity triazolobenzodiazepine anxiolytic whose arterial pressure\u2013lowering interaction with the antifungal ciclopirox is documented. This matches alprazolam\u2019s profile and the Alprazolam\u2013arterial pressure NOS decreased\u2013Ciclopirox interaction.  \nANSWER: Alprazolam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 571, "completion_tokens": 285, "total_tokens": 856, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a8e7481908cd44fce727f06e9", "custom_id": "Temazepam-Zafirlukast_3:upper_bound", "response": {"status_code": 200, "request_id": "363748c2cd56765edadc74dcde598b23", "body": {"id": "chatcmpl-BTyuQvVzOUGLARHbn09id39cMQJK8", "object": "chat.completion", "created": 1746485346, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described scaffold\u2014a diazepine ring (1,4-benzodiazepine) fused to a chlorinated benzene and bearing a phenyl substituent\u2014matches Temazepam\u2019s structure. In the reported interaction, this benzodiazepine (Temazepam) forms hydrogen bonds with Zafirlukast, which contains sulfonamide and carbamate groups on its multi-ring aromatic backbone.  \nANSWER: Temazepam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 367, "completion_tokens": 494, "total_tokens": 861, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7a9f388190bd078a0016a123b6", "custom_id": "Ondansetron-Pirbuterol_0:upper_bound", "response": {"status_code": 200, "request_id": "92729e7c1930fac7657d41bd11bdbba5", "body": {"id": "chatcmpl-BTyuQpmjINMu6Fx0aGx0BAoRC2Pxx", "object": "chat.completion", "created": 1746485346, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple indicates \u201cOndansetron \u2013 loss of weight \u2013 Pirbuterol,\u201d and pirbuterol is described as a short-acting \u03b22 agonist used for bronchodilation in asthma.  \nANSWER: Pirbuterol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 577, "completion_tokens": 389, "total_tokens": 966, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ac3a48190bb638acadd37e9b1", "custom_id": "Temazepam-Zafirlukast-Cysteinyl leukotriene receptor 1_7:upper_bound", "response": {"status_code": 200, "request_id": "8fce0a19c23c78e716745a7295777187", "body": {"id": "chatcmpl-BTyj8nc1FJAZdlNBVoKiFy3WADX0v", "object": "chat.completion", "created": 1746484646, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Zafirlukast is an orally active leukotriene receptor antagonist whose therapeutic effect in asthma stems from binding to and inhibiting the cysteinyl leukotriene receptor 1 (CysLT1), a receptor that mediates allergic and hypersensitivity reactions by binding cysteinyl leukotrienes and promoting bronchoconstriction and inflammation.  \nANSWER: Cysteinyl leukotriene receptor 1", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 883, "completion_tokens": 296, "total_tokens": 1179, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ae40c819082dfb715e7cb80a3", "custom_id": "Temazepam-Megestrol-Desloratadine-Darunavir_2:upper_bound", "response": {"status_code": 200, "request_id": "4f44bc11273bd48dd0a73bf1a639ce65", "body": {"id": "chatcmpl-BTyjEj4a6YLnjgkoDBFOyiSz0Q09M", "object": "chat.completion", "created": 1746484652, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The patient is on desloratadine (the non-sedating tricyclic H1 inverse agonist, active metabolite of loratadine) and then starts an HIV\u20101 protease inhibitor that requires boosting with ritonavir or cobicistat. According to the provided interaction triples, desloratadine plus darunavir is associated with acute pancreatitis.  \nANSWER: Darunavir", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1047, "completion_tokens": 422, "total_tokens": 1469, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7b02688190b6b6813b5e9d76a7", "custom_id": "Alprazolam-Benazepril_3:upper_bound", "response": {"status_code": 200, "request_id": "9e7be758f437a5a01abf792f8d76cef1", "body": {"id": "chatcmpl-BTyjMcgG3bBObbvDJnNslX3Nc40Fw", "object": "chat.completion", "created": 1746484660, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Benazepril contains multiple carbonyl and carboxyl oxygen atoms (the ethoxycarbonyl ester, the amide carbonyl, and the terminal carboxylic acid), each of which is a strong hydrogen\u2010bond acceptor. In contrast, Alprazolam\u2019s heterocyclic nitrogens in its fused triazolobenzodiazepine core are fewer and less available than Benazepril\u2019s oxygen donors.  \nANSWER: Benazepril", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 374, "completion_tokens": 502, "total_tokens": 876, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7b21cc8190bff3f1aab332e740", "custom_id": "Diazepam-Doxazosin_3:upper_bound", "response": {"status_code": 200, "request_id": "3c6615c8df1eb63bc408b7395cf134a2", "body": {"id": "chatcmpl-BTyjXUJweF8oqk3fBaaqWCfIFjJBJ", "object": "chat.completion", "created": 1746484671, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Diazepam features a seven-membered diazepine ring fused to a benzene ring bearing a chlorine substituent. It engages in a direct \u03c0-\u03c0 stacking interaction with doxazosin, which contains a quinazoline core with two methoxy groups and a dioxane-linked phenyl moiety.  \nANSWER: Diazepam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 366, "completion_tokens": 409, "total_tokens": 775, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7b440881908d3f7607d20aa4dd", "custom_id": "Risedronic acid-Imatinib_0:upper_bound", "response": {"status_code": 200, "request_id": "a75927a39fe75189e0444ca74afc6161", "body": {"id": "chatcmpl-BTyjhhtE23TH1vPSvBYUkFVCNxZbu", "object": "chat.completion", "created": 1746484681, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple \u201cRisedronic acid\u2013Sinus headache\u2013Imatinib\u201d indicates that when the bisphosphonate (Risedronic acid) is co-administered with the ATP-competitive inhibitor (Imatinib), the adverse event \u201csinus headache\u201d is linked to Risedronic acid.  \nANSWER: Risedronic acid", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 615, "completion_tokens": 286, "total_tokens": 901, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7b63a88190b3a2c68899f74664", "custom_id": "Norfloxacin-Zolpidem_0:upper_bound", "response": {"status_code": 200, "request_id": "d2430134cde6efdf88e4f473558d2811", "body": {"id": "chatcmpl-BTyjnlNKbzeqngjnSJe8eVjqdRQa1", "object": "chat.completion", "created": 1746484687, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described fluoroquinolone antibiotic used for urinary and gynecological infections and linked to tendon problems is Norfloxacin. In the given interaction triple (Norfloxacin-folate deficiency-Zolpidem), Norfloxacin is reported to cause folate deficiency when interacting with the hypnotic agent Zolpidem.  \nANSWER: Norfloxacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 286, "total_tokens": 985, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7b83c48190a8586944acebe7fd", "custom_id": "Alprazolam-Bumetanide_0:upper_bound", "response": {"status_code": 200, "request_id": "57a592f734fee7b06a5860330c17d21c", "body": {"id": "chatcmpl-BTyjtM37fGEEITQ9fsvbwA9Qu66Di", "object": "chat.completion", "created": 1746484693, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a loop diuretic used to manage edema that, when co-administered with a GABA_A\u2013modulating benzodiazepine (alprazolam), is linked to erythema. The provided interaction triple is Alprazolam\u2013erythema\u2013Bumetanide, identifying the loop diuretic as bumetanide.  \nANSWER: Bumetanide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 728, "completion_tokens": 294, "total_tokens": 1022, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7b9ae88190ac9c13545d3e683f", "custom_id": "Celecoxib-Oxaprozin-Sildenafil_1:upper_bound", "response": {"status_code": 200, "request_id": "ddcac78d66c3d1d149d17e4507f5428b", "body": {"id": "chatcmpl-BTyk1l1b8qAe74Je1p3yys40N16Ns", "object": "chat.completion", "created": 1746484701, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The propionic acid derivative NSAID used for joint pain and stiffness is oxaprozin. The known adverse interaction is Oxaprozin\u2010gastric inflammation\u2010Sildenafil, indicating that gastric inflammation arises when oxaprozin is coadministered with the selective PDE5 inhibitor sildenafil.  \nANSWER: Sildenafil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 975, "completion_tokens": 1106, "total_tokens": 2081, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1024, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7bbc94819098b09605abef26c9", "custom_id": "Rofecoxib-Telmisartan-solifenacin_4:upper_bound", "response": {"status_code": 200, "request_id": "a8bf9c634153b8961a7865de55e01d79", "body": {"id": "chatcmpl-BTykNUPVyJn2p3l4U5xLhkV8WrU4r", "object": "chat.completion", "created": 1746484723, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described bicyclic scaffold\u2014a piperidine fused to a tetrahydroisoquinoline, connected via an ester linkage to a quinuclidine (azabicyclo[2.2.2]octane) moiety\u2014matches solifenacin. Solifenacin engages in a \u03c0-\u03c0 stacking interaction with telmisartan, the angiotensin II receptor antagonist bearing multiple aromatic rings and a tetrazole ring.  \nANSWER: solifenacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 484, "completion_tokens": 756, "total_tokens": 1240, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 640, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7be2288190a08317b9c13b7159", "custom_id": "Carvedilol-Darunavir_0:upper_bound", "response": {"status_code": 200, "request_id": "840d5075e2da9d14667a9c8d9a6e5d2d", "body": {"id": "chatcmpl-BTykcxYGUHlelgrdtbAlUQEOp6gI4", "object": "chat.completion", "created": 1746484738, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Darunavir (with its pharmacokinetic booster) strongly inhibits CYP2D6/2C9, raising carvedilol levels and potentiating its pulmonary side effects (bronchospasm, vasodilation) that can manifest as hemoptysis. Darunavir itself is not associated with coughing up blood, so the interaction\u2013mediated toxicity of carvedilol is the likely cause.  \nANSWER: Carvedilol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 720, "completion_tokens": 750, "total_tokens": 1470, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 640, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7c01748190a8598e42283f7113", "custom_id": "Lidocaine-Pamidronic acid-thiotepa_1:upper_bound", "response": {"status_code": 200, "request_id": "dc475d0fed9fa0da2ece6e64dc67ed09", "body": {"id": "chatcmpl-BTyko5QmNaJ7T2A8OfBRCVBhkrZzQ", "object": "chat.completion", "created": 1746484750, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The nitrogen-containing bisphosphonate used for osteoporosis is pamidronic acid. The organophosphorus anti-cancer drug with formula (C2H4N)3PS and marketed as Tepadina is thiotepa. The interaction data indicate that co-administration of pamidronic acid with thiotepa is associated with an increased risk of erythema.  \nANSWER: Thiotepa", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 822, "completion_tokens": 360, "total_tokens": 1182, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7c1fc88190a4c9d636fcabfa4d", "custom_id": "Loxapine-Histamine H1 receptor_6:upper_bound", "response": {"status_code": 200, "request_id": "ebdf0e6cb980f6728fe5030af1af36e2", "body": {"id": "chatcmpl-BTyky5SG0NxAuhsGCEeOXFTZSUO9X", "object": "chat.completion", "created": 1746484760, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a rhodopsin-like G-protein-coupled receptor that mediates histamine effects in smooth muscle, endothelial cells, and the CNS via Gq-mediated activation of phospholipase C. The provided drug, loxapine, is a tricyclic antipsychotic structurally similar to clozapine that binds and inhibits this receptor. According to the background, that receptor is the Histamine H1 receptor.  \nANSWER: Histamine H1 receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 580, "completion_tokens": 252, "total_tokens": 832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7c41ac819091c492483e756482", "custom_id": "Carvedilol-Darunavir_3:upper_bound", "response": {"status_code": 200, "request_id": "58e0169d7e19f55b8385800f8cc72d6a", "body": {"id": "chatcmpl-BTyl46MpS3mCH0NElUx98mpeUvemg", "object": "chat.completion", "created": 1746484766, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Carvedilol\u2019s methoxyphenoxypropanolamine moiety contains a free \u2013OH on the propanolamine, which serves as a hydrogen\u2010bond donor, whereas Darunavir\u2019s sulfonamide nitrogen (and sulfonyl oxygens) primarily function as acceptors.  \nANSWER: Carvedilol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 363, "completion_tokens": 1815, "total_tokens": 2178, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1728, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7c58908190a47f41c085e1c4b2", "custom_id": "Triazolam-Zaleplon_3:upper_bound", "response": {"status_code": 200, "request_id": "d4793ee0ba574368a0658d548cb3ee23", "body": {"id": "chatcmpl-BTylaDSRyOuEy7Qrg6f5PX2ydEnJU", "object": "chat.completion", "created": 1746484798, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Triazolam is the triazolobenzodiazepine featuring two aromatic rings each bearing chlorine substituents, and it participates in \u03c0\u2013\u03c0 stacking with Zaleplon, a pyrazolopyrimidine derivative bearing a nitrile group and an N-ethylacetamide side chain.  \nANSWER: Triazolam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 353, "completion_tokens": 411, "total_tokens": 764, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7c77108190ab01b9c1763c18db", "custom_id": "Fluorouracil-vincristine_3:upper_bound", "response": {"status_code": 200, "request_id": "adaeccd415c5e32a7b84847dd8dc5546", "body": {"id": "chatcmpl-BTyllT4AkgxWlsZrkGjpwUiw5jLiU", "object": "chat.completion", "created": 1746484809, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Fluorouracil\u2019s pyrimidine\u2010dione core contains two N\u2013H groups capable of donating hydrogen bonds, whereas vincristine\u2019s many carbonyl and ether oxygens act primarily as acceptors. Thus in the cited Fluorouracil\u2013Hydrogen Bonding\u2013vincristine interaction, Fluorouracil serves as the hydrogen\u2010bond donor.  \nANSWER: Fluorouracil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 406, "completion_tokens": 426, "total_tokens": 832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7c9ae881909a6b20398f62a42d", "custom_id": "Haloperidol-Histamine H1 receptor_6:upper_bound", "response": {"status_code": 200, "request_id": "bb4a57bdee6b922e3df2309032339676", "body": {"id": "chatcmpl-BTylujMKxk4uprU1DmgSwpOSHk6nP", "object": "chat.completion", "created": 1746484818, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a rhodopsin-like GPCR activated by histamine and involved in allergic responses, which is directly bound and inhibited by the butyrophenone antipsychotic haloperidol. The provided interaction triple identifies this target as the Histamine H1 receptor.  \nANSWER: Histamine H1 receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 688, "completion_tokens": 279, "total_tokens": 967, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7cb2dc8190af90070f40f2f9e9", "custom_id": "Naproxen-Norfloxacin_3:upper_bound", "response": {"status_code": 200, "request_id": "060120e5e9d0f469e5a9d9d2e4c41e83", "body": {"id": "chatcmpl-BTym0Y0zTnTtNDmBX8WUPH40foKSx", "object": "chat.completion", "created": 1746484824, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Naproxen\u2019s carboxylic acid (\u2013COOH) group can donate a hydrogen bond, whereas Norfloxacin\u2019s quinolone carbonyls, carboxylate, and ring nitrogens provide lone\u2010pair sites that accept hydrogen bonds. Thus in the Naproxen\u2013Norfloxacin interaction, Norfloxacin serves as the hydrogen\u2010bond acceptor.  \nANSWER: Norfloxacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 342, "completion_tokens": 744, "total_tokens": 1086, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 640, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7cd4688190a2cc7f0df1e227ff", "custom_id": "Naproxen-alendronic acid-Salmeterol-Beta-1 adrenergic receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "72e5c7c1c228dd656c115604b9c6ef65", "body": {"id": "chatcmpl-BTymIH5f02y8CoDR1zjzq2TrMQ5Kz", "object": "chat.completion", "created": 1746484842, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes Salmeterol\u2014a long\u2010acting inhaled medication for asthma and COPD that, when combined with the bisphosphonate alendronic acid, may precipitate cholecystitis. According to the provided interaction triple (\u201cSalmeterol\u2013binding and activation\u2013Beta-1 adrenergic receptor\u201d) and the protein background (a Gs\u2010coupled GPCR in heart and cerebral cortex), Salmeterol binds to and activates the Beta-1 adrenergic receptor.  \nANSWER: Beta-1 adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1097, "completion_tokens": 580, "total_tokens": 1677, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7cf7348190aa633b903e0a5d6a", "custom_id": "Orphenadrine-Temazepam_3:upper_bound", "response": {"status_code": 200, "request_id": "839ba03dad12fbd894a44f54eff88765", "body": {"id": "chatcmpl-BTymPMKuRHpUlBunMLsnjuUgsrgmH", "object": "chat.completion", "created": 1746484849, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Temazepam contains the 1,4-benzodiazepin-2-one scaffold bearing both a hydroxyl and a ketone group, enabling it to form hydrogen bonds with Orphenadrine.  \nANSWER: Temazepam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 328, "completion_tokens": 262, "total_tokens": 590, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7d1f0881908f2f6e8d38f58c62", "custom_id": "alendronic acid-Indapamide_3:upper_bound", "response": {"status_code": 200, "request_id": "132e1553e74342b26e3f8f84a7b57c97", "body": {"id": "chatcmpl-BTymUlQl9C4dy107Gri6ZrWy5reFB", "object": "chat.completion", "created": 1746484854, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Alendronic acid bears two phosphonic acid \u2013OH groups and a primary \u2013NH\u2082, all of which can donate hydrogen bonds. Indapamide\u2019s sulfonamide and amide nitrogens have fewer available H-donors. Thus, in the alendronic acid\u2013indapamide hydrogen-bonding interaction, alendronic acid is the donor.  \nANSWER: alendronic acid", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 341, "completion_tokens": 935, "total_tokens": 1276, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 832, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7d3c0081909fee5b4424051288", "custom_id": "Fentanyl-Labetalol-Alpha-1B adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "d991ffbda81fb76bfcbfdf09f58cab4e", "body": {"id": "chatcmpl-BTyj9gmH6OJbepg9m7iKdHlg3Rqra", "object": "chat.completion", "created": 1746484647, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Labetalol lowers blood pressure by blocking \u03b2- and \u03b1-adrenergic receptors. Its \u03b1-receptor target, whose crystal structure has been solved bound to the inverse agonist (+)-cyclazosin, is the \u03b1\u2081B-adrenergic receptor.  \nANSWER: Alpha-1B adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 904, "completion_tokens": 409, "total_tokens": 1313, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7d5a648190960c19d3c04fc62e", "custom_id": "Naproxen-Lamotrigine-Zolpidem_1:upper_bound", "response": {"status_code": 200, "request_id": "e4ee93c9273ded95144730fcb99a72c1", "body": {"id": "chatcmpl-BTyj8JFCj72XSOaNp23CX4KedI0nH", "object": "chat.completion", "created": 1746484646, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The patient is on lamotrigine, which modulates voltage-gated sodium and calcium channels to inhibit excitatory neurotransmitter release. Zolpidem is a short-acting hypnotic that decreases sleep latency by enhancing GABAA receptor\u2013mediated inhibition. The lamotrigine\u2013zolpidem combination has been linked to interstitial cystitis.  \nANSWER: Zolpidem", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1110, "completion_tokens": 294, "total_tokens": 1404, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7d77788190b1c421c29c2692dd", "custom_id": "Lamotrigine-Salmeterol-Beta-3 adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "6ead61bf6ee226f3b91a10e96b9d6af3", "body": {"id": "chatcmpl-BTyj8QSUDTkAwq5msTdnklbq2s1s9", "object": "chat.completion", "created": 1746484646, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Salmeterol is a long-acting \u03b22 agonist delivered via dry-powder inhaler for asthma/COPD and is documented to bind and activate the receptor encoded by the ADRB3 gene, namely the beta-3 adrenergic receptor.  \nANSWER: Beta-3 adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 764, "completion_tokens": 276, "total_tokens": 1040, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7d95648190b34600a4ec4fac86", "custom_id": "Lamotrigine-Zaleplon_0:upper_bound", "response": {"status_code": 200, "request_id": "ace160b80be10c2eaf07a9e8a539d526", "body": {"id": "chatcmpl-BTyjCvdNG126g7hgVTYWj2Vvum3Cl", "object": "chat.completion", "created": 1746484650, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cLamotrigine \u2013 apoplexy \u2013 Zaleplon\u201d indicates that Lamotrigine, when co-administered with Zaleplon, is the agent associated with inducing apoplexy.  \nANSWER: Lamotrigine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 589, "completion_tokens": 400, "total_tokens": 989, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7db6e8819092792d6992a1a1d4", "custom_id": "alendronic acid-Alprazolam-Doxazosin-Alpha-1B adrenergic receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "de88f64482048db36b9ddd17d60855b7", "body": {"id": "chatcmpl-BTyjCNE1jiAhqOHbNu0LRC3TODyDM", "object": "chat.completion", "created": 1746484650, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Doxazosin is a selective \u03b11-adrenergic receptor blocker whose antihypertensive and urinary\u2010symptom effects arise from inhibition of the \u03b11B subtype.  \nANSWER: Alpha-1B adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1074, "completion_tokens": 261, "total_tokens": 1335, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7dd2bc819082efae9ff56f21f7", "custom_id": "Haloperidol-oxybutynin_0:upper_bound", "response": {"status_code": 200, "request_id": "a9a78b1178a98c521e5d5f3ae0157021", "body": {"id": "chatcmpl-BTyjDaa9HYcJSvPECBUqqXOYcJOIL", "object": "chat.completion", "created": 1746484651, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a drug that antagonizes central dopaminergic D2 receptors to treat psychotic disorders and, in combination with the anticholinergic oxybutynin, can precipitate an apoplexy. This profile matches haloperidol, a butyrophenone derivative and typical antipsychotic known for potent D2 receptor antagonism.  \nANSWER: Haloperidol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 781, "completion_tokens": 228, "total_tokens": 1009, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7e06c48190bbd70825c511af50", "custom_id": "Carvedilol-Ibuprofen-Midodrine_1:upper_bound", "response": {"status_code": 200, "request_id": "f688ea6f4ae0ec22251a108b5e1d16a4", "body": {"id": "chatcmpl-BTyjFRwBHrGSbaTZPQjouN4is5sYn", "object": "chat.completion", "created": 1746484653, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple \u201cIbuprofen\u2013dry skin\u2013Midodrine\u201d indicates that when the NSAID (ibuprofen) is coadministered with the \u03b11-agonist prodrug (midodrine), a dry skin adverse effect is most likely.  \r\nANSWER: Midodrine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 997, "completion_tokens": 273, "total_tokens": 1270, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7e36ac81908a9e317434409ad8", "custom_id": "Carvedilol-Metolazone-Metoprolol-Alpha-2C adrenergic receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "185e61c6424c680aa1c0c223e8ac4eb8", "body": {"id": "chatcmpl-BTyjH9pvGOwzF0MXEuupEewU30HG9", "object": "chat.completion", "created": 1746484655, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes metoprolol\u2014a cardioselective \u03b21-adrenergic antagonist with CYP2D6-mediated metabolism and side effects like insomnia and gastrointestinal disturbances\u2014which, per the provided interaction data, binds to and inhibits the receptor encoded by ADRA2C.  \nANSWER: Alpha-2C adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1045, "completion_tokens": 281, "total_tokens": 1326, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7e512c819085a1416a728b69f3", "custom_id": "Fluorouracil-mitomycin C_3:upper_bound", "response": {"status_code": 200, "request_id": "f5a420faf8c5d4fc8ac3979cbef74261", "body": {"id": "chatcmpl-BTyjIiXlmXI0WBoyx585Spz4UHTGp", "object": "chat.completion", "created": 1746484656, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple states \u201cFluorouracil \u2013 Hydrogen Bond (Donor\u2010Acceptor) \u2013 mitomycin C,\u201d indicating Fluorouracil is the hydrogen bond donor and mitomycin C is the acceptor.  \nANSWER: Fluorouracil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 346, "completion_tokens": 336, "total_tokens": 682, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7e6b508190ac92c1d161a33ded", "custom_id": "Ziprasidone-Desloratadine_0:upper_bound", "response": {"status_code": 200, "request_id": "56806a28a516d7f72949417cec5684c3", "body": {"id": "chatcmpl-BTyjMm78PU5blK6aS5roSsZCkmoEU", "object": "chat.completion", "created": 1746484660, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple \u201cZiprasidone-heart rate increased-Desloratadine\u201d indicates that when these two drugs are co-administered, ziprasidone is responsible for the observed increase in heart rate. Desloratadine\u2019s antihistaminic action does not typically provoke tachycardia, whereas ziprasidone\u2019s effects on cardiac ion channels can lead to increased heart rate.  \nANSWER: Ziprasidone", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 626, "completion_tokens": 560, "total_tokens": 1186, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7e85948190b6330fe80bac56b5", "custom_id": "alendronic acid-Lamivudine-Metoprolol-Perphenazine_5:upper_bound", "response": {"status_code": 200, "request_id": "802e694368ac566ef6068f3230fb02e6", "body": {"id": "chatcmpl-BTyjNaiTJoiD5y0ZQvIyh3OQNnkAk", "object": "chat.completion", "created": 1746484661, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The beta-blocker described is metoprolol (a para-substituted phenyl ring linked via an ether to an isopropylamino ethanol side chain). The interaction data shows Metoprolol forms hydrogen bonds with Perphenazine. Perphenazine is the drug featuring a chlorinated tricyclic phenothiazine core with a piperazine ring.  \nANSWER: Perphenazine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 492, "completion_tokens": 680, "total_tokens": 1172, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 576, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ea1ec81908596c6ca31604521", "custom_id": "Cimetidine-Citalopram-nevirapine-oxybutynin_2:upper_bound", "response": {"status_code": 200, "request_id": "c75873669c9791f02e905f287cde5d8e", "body": {"id": "chatcmpl-BTyjPH74KElKLbCC2agTeDndeiIAy", "object": "chat.completion", "created": 1746484663, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The patient is on nevirapine, a non-nucleoside reverse transcriptase inhibitor for HIV-1. The provided interaction triple \u201cnevirapine-emesis-oxybutynin\u201d indicates that adding oxybutynin, an anticholinergic used for overactive bladder (with known adverse effects xerostomia and urinary retention), increases the risk of emesis.  \nANSWER: oxybutynin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1261, "completion_tokens": 364, "total_tokens": 1625, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ebd288190a53ec2087e1d6e29", "custom_id": "Celecoxib-Midodrine_3:upper_bound", "response": {"status_code": 200, "request_id": "6195c4b1b10bb83210ab4ceebd37df98", "body": {"id": "chatcmpl-BTyjWIIjg9XW6vuZC8LBVB0L9Hhnd", "object": "chat.completion", "created": 1746484670, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Celecoxib bears a sulfonamide (\u2013SO\u2082NH\u2013) moiety, which provides both hydrogen\u2010bond donor (NH) and acceptor (S=O) sites that can pair with Midodrine\u2019s amine and amide functionalities.  \nANSWER: Celecoxib", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 371, "completion_tokens": 1104, "total_tokens": 1475, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1024, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ed9388190a03d717e100328c4", "custom_id": "Metronidazole-Fosphenytoin_3:upper_bound", "response": {"status_code": 200, "request_id": "31f1e5eed22f267667761a517adb10ac", "body": {"id": "chatcmpl-BTyjZOlSlF1egSPOgx7Kdu0E7uGpN", "object": "chat.completion", "created": 1746484673, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Metronidazole carries a hydroxyethyl side chain (\u2013CH2CH2\u2013OH) and secondary amine nitrogens, both of which can donate hydrogen bonds. Fosphenytoin\u2019s hydantoin core and phosphono groups only provide acceptor oxygens.  \nANSWER: Metronidazole", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 353, "completion_tokens": 278, "total_tokens": 631, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ef9588190ba8283dbd53e6515", "custom_id": "Lamotrigine-Oxaprozin_3:upper_bound", "response": {"status_code": 200, "request_id": "b4946af03749c0412059f4b26d9b636e", "body": {"id": "chatcmpl-BTyjZzPZe27ZjycG3oFGbqszfUlzt", "object": "chat.completion", "created": 1746484673, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Lamotrigine\u2019s triazine core contains multiple ring nitrogens with lone pairs that can serve as hydrogen\u2010bond acceptors. Oxaprozin\u2019s carboxylic acid provides the hydrogen donor. Thus in the Lamotrigine\u2013Hydrogen Bond\u2013Oxaprozin interaction, Lamotrigine is the acceptor.  \nANSWER: Lamotrigine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 360, "completion_tokens": 929, "total_tokens": 1289, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 832, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7f129c819083467f83494aeda9", "custom_id": "Candesartan-Perindopril_3:upper_bound", "response": {"status_code": 200, "request_id": "94375877e3c49661a328607ac8279197", "body": {"id": "chatcmpl-BTyjgXjJElQApvlCuZde8fFdSfBpZ", "object": "chat.completion", "created": 1746484680, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Candesartan\u2019s biphenyl-tetrazole scaffold contains four electron-rich tetrazole nitrogens, providing stronger lone\u2010pair density for hydrogen\u2010bond acceptance than the single secondary amide and ester nitrogens of perindopril.  \nANSWER: Candesartan", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 384, "completion_tokens": 336, "total_tokens": 720, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7f2cf48190a186f8b8141eac2b", "custom_id": "Bumetanide-Ranolazine_3:upper_bound", "response": {"status_code": 200, "request_id": "b52ebcf0bf1a4f4196ed9da6944ebf2a", "body": {"id": "chatcmpl-BTyjneOjHfmURGA0oqMK63Ir8lV6J", "object": "chat.completion", "created": 1746484687, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The sulfonamide-bearing drug with the butyl side chain is Bumetanide, and the interaction triple lists \u201cBumetanide\u2013Hydrogen Bonding\u2013Ranolazine,\u201d indicating that Bumetanide is the molecule forming hydrogen bonds with Ranolazine.  \nANSWER: Bumetanide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 357, "completion_tokens": 465, "total_tokens": 822, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7f432c81909c5c443f5deb460d", "custom_id": "Methylphenidate-Ofloxacin-Imatinib_4:upper_bound", "response": {"status_code": 200, "request_id": "87714b3336a05d0f59a775025b4bf4b9", "body": {"id": "chatcmpl-BTyjpPMCBEeNhchAQDxE3hUJzXdBB", "object": "chat.completion", "created": 1746484689, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Imatinib is the only one of the three that bears a piperazine ring (the N3CCN(CC3)C moiety) and a 2-phenylaminopyrimidine (\u201cfused pyrimidine-phenyl\u201d) core. It is also the partner in the Ofloxacin\u2013Hydrogen Bonding\u2013Imatinib interaction, and Ofloxacin is the fluoroquinolone derivative featuring a morpholine\u2010type ring attached to a fluorinated aromatic system.  \nANSWER: Imatinib", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 442, "completion_tokens": 2046, "total_tokens": 2488, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1920, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7f64e48190bea26e22fde74ee8", "custom_id": "Rofecoxib-Triazolam_0:upper_bound", "response": {"status_code": 200, "request_id": "330593073f9b0f30bb0a6b63dcbc6d77", "body": {"id": "chatcmpl-BTyjuh0yHDxDUpZXFPbMmtG4hfgIF", "object": "chat.completion", "created": 1746484694, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple indicates that rofecoxib, when coadministered with the triazolobenzodiazepine triazolam, is linked to an increased risk of cholecystitis.  \nANSWER: Rofecoxib", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 669, "completion_tokens": 137, "total_tokens": 806, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 64, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7f832481908ff019edbb3a37b3", "custom_id": "Celecoxib-Labetalol_3:upper_bound", "response": {"status_code": 200, "request_id": "12d7ed98fcb0af9228eedb96aba98d94", "body": {"id": "chatcmpl-BTyjvYkrfJiPJVzJjBuXUEVfh1SIf", "object": "chat.completion", "created": 1746484695, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Labetalol bears both a secondary amine N\u2013H and a phenolic OH (plus an amide NH\u2082) capable of donating hydrogen bonds, whereas celecoxib\u2019s sulfonamide N\u2013H is less accessible and its sulfonyl oxygens primarily serve as acceptors. Thus in the celecoxib\u2013hydrogen bonding\u2013labetalol interaction, labetalol donates the hydrogen bond.  \nANSWER: Labetalol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 366, "completion_tokens": 1394, "total_tokens": 1760, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1280, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7f9fd08190890e3ef2a47d3643", "custom_id": "indometacin-oxybutynin_3:upper_bound", "response": {"status_code": 200, "request_id": "b49c903750e8319ccd05119b971e59da", "body": {"id": "chatcmpl-BTyj9Dzm2LNOpguiZFgJiVkn2RBpj", "object": "chat.completion", "created": 1746484647, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Indometacin contains a carboxylic acid (\u2013COOH) group, which readily donates a proton in hydrogen\u2010bonding interactions. Although oxybutynin has a tertiary alcohol, the carboxyl proton of indometacin is the primary hydrogen\u2010bond donor in their mutual interaction.  \nANSWER: indometacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 373, "completion_tokens": 793, "total_tokens": 1166, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 704, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7fc0e4819094e90e7413be5848", "custom_id": "Famotidine-Pirbuterol_0:upper_bound", "response": {"status_code": 200, "request_id": "294ed37402f6ef27a0c0644b54f6c53b", "body": {"id": "chatcmpl-BTyjKXj7xHhmWmCESQCOOnW3iH5Hb", "object": "chat.completion", "created": 1746484658, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cFamotidine\u2013elevated cholesterol\u2013Pirbuterol\u201d indicates that Famotidine, when combined with the short-acting \u03b22-agonist Pirbuterol (a breath-activated inhaler), is linked to an increased cholesterol risk.  \nANSWER: Famotidine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 502, "completion_tokens": 336, "total_tokens": 838, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7fdc1081909ef2cc62c825d806", "custom_id": "Ranitidine-Sibutramine-Zolpidem-vincristine_5:upper_bound", "response": {"status_code": 200, "request_id": "2f2ed7e1bc9713eec56e59975272cd5a", "body": {"id": "chatcmpl-BTyjPFb9eYv4rGS6bPVKUfN4TBljA", "object": "chat.completion", "created": 1746484663, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Vincristine is the highly complex polycyclic molecule with multiple fused rings and ester groups, and it is reported to undergo steric clashes with Zolpidem, which contains a substituted imidazopyridine core and an N,N-dimethylacetamide moiety.  \nANSWER: vincristine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 566, "completion_tokens": 533, "total_tokens": 1099, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a7ff3cc8190b876c6e7c2e90b46", "custom_id": "Fentanyl-Ketorolac-oxybutynin-Zaleplon_5:upper_bound", "response": {"status_code": 200, "request_id": "5bf724e3804361b95603b8417bf3dc7f", "body": {"id": "chatcmpl-BTyja1ImseQqwwxwGlsFAKrlwyCk7", "object": "chat.completion", "created": 1746484674, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described scaffold\u2014pyrazolopyrimidine fused ring with a cyano (C#N) and methyl substituent plus an N-ethylacetamide side chain\u2014matches Zaleplon\u2019s structure. According to the interaction data, Zaleplon engages in a \u03c0\u2013\u03c0 stacking interaction with oxybutynin, which is a tertiary amine\u2013containing ether-substituted cyclohexylbenzene.  \nANSWER: Zaleplon", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 518, "completion_tokens": 629, "total_tokens": 1147, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a802d0c819092571e469ebf2e1c", "custom_id": "Labetalol-Metoprolol-Perphenazine-Alpha-2A adrenergic receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "7f8c8cb37e9a8c1afce71fed07911cb9", "body": {"id": "chatcmpl-BTyjlPJCVP5qZxZQ57OrwPFDC0KmP", "object": "chat.completion", "created": 1746484685, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Perphenazine is the medium-potency antipsychotic originally marketed as Trilafon and is about ten times as potent as chlorpromazine at D2 receptors. It directly binds to and inhibits the alpha-2A adrenergic receptor. Perphenazine is also involved in a drug\u2013drug interaction with metoprolol, the cardioselective \u03b21-adrenergic blocker used for hypertension and migraine prophylaxis.  \nANSWER: Alpha-2A adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 943, "completion_tokens": 889, "total_tokens": 1832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 768, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a804a548190984cf2ee06e550a7", "custom_id": "alendronic acid-Efavirenz-Lamivudine-Metoprolol_2:upper_bound", "response": {"status_code": 200, "request_id": "9ff073b643022f8012e1ddbfdf690030", "body": {"id": "chatcmpl-BTyk19arCYmYeiWYckaaUeGCGChpN", "object": "chat.completion", "created": 1746484701, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The nucleoside reverse transcriptase inhibitor described is lamivudine, which can cause gastrointestinal disturbances and lactic acidosis. The patient develops dysarthria when this agent is coadministered with a cardioselective \u03b21-adrenergic antagonist used for angina, hypertension, and migraine prophylaxis whose clearance varies with CYP2D6 activity. This interaction triple is lamivudine\u2013dysarthria\u2013metoprolol, and metoprolol fits the \u03b21-selective, CYP2D6-metabolized profile.  \nANSWER: Metoprolol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1230, "completion_tokens": 464, "total_tokens": 1694, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a806d78819086b218f76d7abc9b", "custom_id": "Amlodipine-Rosiglitazone_0:upper_bound", "response": {"status_code": 200, "request_id": "a2d00d936af36ac3e044448062c466ad", "body": {"id": "chatcmpl-BTykDnFNIzC6PijQ3z5f6X4SsHAIl", "object": "chat.completion", "created": 1746484713, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The documented drug\u2013drug interaction triple is \u201cAmlodipine\u2013apoplexy\u2013Rosiglitazone.\u201d Rosiglitazone is the thiazolidinedione-class PPAR\u03b3 agonist, and the interacting agent associated with increased apoplexy risk when combined with it is Amlodipine.  \nANSWER: Amlodipine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 628, "completion_tokens": 288, "total_tokens": 916, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a80963c8190ace263290615b3c8", "custom_id": "Fentanyl-Labetalol-Metoprolol-Pirbuterol_2:upper_bound", "response": {"status_code": 200, "request_id": "b7eea9f2297ef2a17ce700d791182a94", "body": {"id": "chatcmpl-BTykLQjOl8vQiwn7zh6OL0yFuDcHF", "object": "chat.completion", "created": 1746484721, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The \u03b21-selective antagonist for angina and hypertension is metoprolol, and the breath-activated short-acting \u03b22 agonist used for asthma is pirbuterol. The provided interaction triple \u201cMetoprolol-erythema-Pirbuterol\u201d indicates that when metoprolol is combined with pirbuterol, erythema can occur.  \nANSWER: Pirbuterol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1145, "completion_tokens": 355, "total_tokens": 1500, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a80ad8c81908bb0e3da4029c454", "custom_id": "Bumetanide-Fenofibrate_0:upper_bound", "response": {"status_code": 200, "request_id": "67555ddbd3ae6d7cc4e54d84927fb94f", "body": {"id": "chatcmpl-BTykT7hvMsMGv4qpCdu56QPZ8IY5r", "object": "chat.completion", "created": 1746484729, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cBumetanide\u2013hepatic neoplasia\u2013Fenofibrate\u201d indicates that coadministration of fenofibrate with bumetanide is linked to an elevated risk of hepatic neoplasia.  \nANSWER: Fenofibrate", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 768, "completion_tokens": 776, "total_tokens": 1544, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 704, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a80c56081908afc49350f335971", "custom_id": "Famotidine-Pilocarpine_3:upper_bound", "response": {"status_code": 200, "request_id": "724fe7ba7201a6a8a8b70051d71fa59b", "body": {"id": "chatcmpl-BTykkGPoWpzlESklMLSJuVg0o47kr", "object": "chat.completion", "created": 1746484746, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The thiazole-containing molecule (famotidine) carries multiple electron\u2010rich heteroatoms (sulfonamide oxygens, amidino nitrogens) that serve primarily as hydrogen\u2010bond acceptors. Pilocarpine\u2019s dihydrofuranone ring does feature an acceptor carbonyl, but in the reported pairing the more potent acceptor sites reside on famotidine\u2019s sulfonyl and amidino groups.  \nANSWER: Famotidine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 330, "completion_tokens": 819, "total_tokens": 1149, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 704, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a80e1e88190b0144b24c7a7df54", "custom_id": "Fentanyl-Loxapine-Alpha-2C adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "84da4152bc87df3022e839fc4e66b447", "body": {"id": "chatcmpl-BTyl0ECqMOMODKd92DLS0NaT9ExnM", "object": "chat.completion", "created": 1746484762, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question refers to loxapine, an antipsychotic that is N-demethylated to amoxapine and, when combined with fentanyl, produces deglutition disorder. From the interaction data, loxapine binds to and inhibits the alpha-2C adrenergic receptor.  \nANSWER: Alpha-2C adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 783, "completion_tokens": 353, "total_tokens": 1136, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a80fdd88190941f6b1da4bf24a8", "custom_id": "Naproxen-Zolpidem_0:upper_bound", "response": {"status_code": 200, "request_id": "38ac4543802b571c4b44c50171cd54d3", "body": {"id": "chatcmpl-BTyl9GBUifVbQco7ecT4mVJ0HEnHA", "object": "chat.completion", "created": 1746484771, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The nonbenzodiazepine hypnotic in the interaction triple Naproxen\u2013adenomyosis\u2013Zolpidem is Zolpidem, which is indicated for short-term management of insomnia and acts as a positive allosteric modulator at the GABAA receptor.  \nANSWER: Zolpidem", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 831, "completion_tokens": 278, "total_tokens": 1109, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a81172c8190afc1da40f4658ce2", "custom_id": "Furosemide-vincristine_0:upper_bound", "response": {"status_code": 200, "request_id": "f34476a1ae8f98e51597ce53631c537a", "body": {"id": "chatcmpl-BTylH73WdM2B5XSfCGFPumYza03Gr", "object": "chat.completion", "created": 1746484779, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple (\u201cFurosemide\u2013amyloidosis\u2013vincristine\u201d) indicates that furosemide has been reported in the literature to interact with vincristine in the context of amyloidosis.  \nANSWER: Furosemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 786, "completion_tokens": 329, "total_tokens": 1115, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8137dc8190b49b2925984579ef", "custom_id": "Ketorolac-Duloxetine_0:upper_bound", "response": {"status_code": 200, "request_id": "b0e1b3d309117e5c1f52d6dd04a1bef0", "body": {"id": "chatcmpl-BTylNVYBkyPMPCZF2R6mkctItf0Eb", "object": "chat.completion", "created": 1746484785, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Ketorolac exerts its analgesic effect by inhibiting COX-1/COX-2\u2013mediated prostaglandin synthesis and is approved only for short-term management of moderate to severe nociceptive pain. It lacks efficacy in treating neuropathic or centrally sensitized pain syndromes such as neuropathic back injury, a domain in which duloxetine (an SNRI) has demonstrated benefit.  \nANSWER: Ketorolac", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 827, "completion_tokens": 305, "total_tokens": 1132, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a814c948190a34532fd51d6b434", "custom_id": "Furosemide-hydralazine_3:upper_bound", "response": {"status_code": 200, "request_id": "341c38cdf6becb28547e39af79e8d9e8", "body": {"id": "chatcmpl-BTylU17hWCwjnHWoBMZZv5HWAmBtF", "object": "chat.completion", "created": 1746484792, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Furosemide\u2019s carboxylate, sulfonyl, and furan oxygen atoms serve as hydrogen\u2010bond acceptors, whereas hydralazine\u2019s hydrazine NH groups act as donors.  \nANSWER: Furosemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 351, "completion_tokens": 518, "total_tokens": 869, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a816cdc81908fa9c272de5393db", "custom_id": "Diazepam-Desloratadine_3:upper_bound", "response": {"status_code": 200, "request_id": "ef7563a4d9d4332c9bc35fb6264391f7", "body": {"id": "chatcmpl-BTylkJ3JenvRm2s0c0bJvGnBYi77i", "object": "chat.completion", "created": 1746484808, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: In \u03c0\u2013\u03c0 stacking the electron\u2010poor (\u201cdeficient\u201d) aromatic system serves as the \u03c0\u2010acceptor. Desloratadine\u2019s tricyclic core contains a chlorinated benzene and a pyridine ring (both electron\u2010withdrawing), making it more electron\u2010deficient than diazepam\u2019s phenyl\u2010fused diazepine system. Thus Desloratadine is the \u03c0\u2010acceptor.  \nANSWER: Desloratadine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 377, "completion_tokens": 497, "total_tokens": 874, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8187248190a7a27941efd73f15", "custom_id": "Haloperidol-indometacin-vincristine-Torasemide_5:upper_bound", "response": {"status_code": 200, "request_id": "dda3cd7d5e8414d96e50b10c884c50c4", "body": {"id": "chatcmpl-BTylxMs7QAN2mCbi1yHPzo7ro68hg", "object": "chat.completion", "created": 1746484821, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described scaffold \u2013 a phenylamino-pyridine core linked via a sulfonamide to an acylguanidine moiety \u2013 matches Torasemide\u2019s structure. According to the interaction triples, Torasemide forms hydrogen bonds with the multi-ringed indole-based anticancer agent vincristine.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 579, "completion_tokens": 541, "total_tokens": 1120, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a81af308190805cd82f2d4cb9f3", "custom_id": "Theophylline-Bumetanide-vincristine-Torasemide_5:upper_bound", "response": {"status_code": 200, "request_id": "f984240f0273b257a9d2b29183aba666", "body": {"id": "chatcmpl-BTym8Inv6Nyf8XYXLKslrGT22pIRH", "object": "chat.completion", "created": 1746484832, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug described (a methylated aniline plus a sulfonylurea moiety fused to a pyridine) matches Torasemide\u2019s structure. According to the interaction triples, Torasemide hydrogen-bonds with vincristine, the complex dimeric indole\u2013indoline alkaloid that itself hydrogen-bonds with the sulfonamide loop diuretic bumetanide.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 571, "completion_tokens": 1133, "total_tokens": 1704, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1024, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a81ceb0819097dd2bd8e9c76b16", "custom_id": "Naproxen-Carvedilol_0:upper_bound", "response": {"status_code": 200, "request_id": "712c26dbb8a768f81c8315aa92061cf3", "body": {"id": "chatcmpl-BTymLTHo8no3Tuw7sBTw5n92XjVWL", "object": "chat.completion", "created": 1746484845, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described drug is a nonselective \u03b2-adrenergic blocker with \u03b1\u2081-receptor antagonism used in heart failure and hypertension, which in the provided interaction triple (Naproxen\u2013adenopathy\u2013Carvedilol) is the drug linked to adenopathy when interacting with the NSAID Naproxen.ANSWER: Carvedilol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 744, "completion_tokens": 287, "total_tokens": 1031, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a81e89881908de3e238b16883b2", "custom_id": "Diazepam-Temozolomide-Thalidomide_4:upper_bound", "response": {"status_code": 200, "request_id": "3602bfb3687d47e0be4e2e89b63f304e", "body": {"id": "chatcmpl-BTymQuIX0218OWwExIVEf4yXhdfiT", "object": "chat.completion", "created": 1746484850, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The glutarimide ring fused to a phthalimide moiety describes thalidomide. In the interaction network, temozolomide (an imidazotetrazine with a triazene) accepts an H-bond from diazepam (a chlorinated benzodiazepine) and donates an H-bond to thalidomide.  \nANSWER: Thalidomide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 438, "completion_tokens": 362, "total_tokens": 800, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8204ac81908c871a6ca53cadf3", "custom_id": "alendronic acid-Imatinib_3:upper_bound", "response": {"status_code": 200, "request_id": "ee98f02848b357304446bafc79d19526", "body": {"id": "chatcmpl-BTyjD7Z12qMEtZGJXxGDVYcaBsOuT", "object": "chat.completion", "created": 1746484651, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The phosphonic acid OH groups and primary amine of alendronic acid serve primarily as hydrogen\u2010bond donors, whereas the amide carbonyl (and tertiary nitrogens) in imatinib serve as hydrogen\u2010bond acceptors.  \nANSWER: Imatinib", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 357, "completion_tokens": 524, "total_tokens": 881, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a821f608190a4c99e94552c2705", "custom_id": "Risedronic acid-Trazodone-Alpha-2C adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "f36283634cd96dcd318e37320c30541d", "body": {"id": "chatcmpl-BTyjLB5DCtUj1SARiYlNmFr8uPJpY", "object": "chat.completion", "created": 1746484659, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The sedating antidepressant described is trazodone, a serotonin antagonist and reuptake inhibitor. From the provided interaction data, trazodone binds to and inhibits the alpha-2C adrenergic receptor, which is encoded by the ADRA2C gene.  \nANSWER: Alpha-2C adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 632, "completion_tokens": 215, "total_tokens": 847, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a823b7c819088d5aff14e4562fb", "custom_id": "Rofecoxib-Zolpidem-vincristine-Torasemide_2:upper_bound", "response": {"status_code": 200, "request_id": "3543d62231576729c416ce4d7c04753c", "body": {"id": "chatcmpl-BTyjPQknDaa14dvExGj2Kb7oxPzqY", "object": "chat.completion", "created": 1746484663, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The intravenous vinca alkaloid described is vincristine, and the sulfonamide loop diuretic used for fluid overload\u2014ranked 184th in U.S. prescriptions in 2022\u2014is torasemide. The provided interaction triple (vincristine-drug toxicity NOS-Torasemide) identifies torasemide as the loop diuretic responsible for the toxicity interaction.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1346, "completion_tokens": 428, "total_tokens": 1774, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8250e481909f957ac5a729a44a", "custom_id": "Candesartan-Fenofibrate-Modafinil-Bimatoprost_2:upper_bound", "response": {"status_code": 200, "request_id": "9cca1a2a17d5836d382428f7ccd6f633", "body": {"id": "chatcmpl-BTyjbmqbOKGk04odUZ7IjQBgZPLHn", "object": "chat.completion", "created": 1746484675, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The ophthalmic prostaglandin analog used to lower intraocular pressure in glaucoma and to enhance eyelash growth\u2014known for reversible eye color changes and administered as an eye drop\u2014is bimatoprost. In the provided interaction triples, modafinil\u2009\u2013\u2009a CNS stimulant for narcolepsy\u2009\u2013\u2009interacts with bimatoprost to produce nocturia.  \nANSWER: Bimatoprost", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1137, "completion_tokens": 360, "total_tokens": 1497, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a827c408190957969d58bdda972", "custom_id": "Diazepam-Ofloxacin_0:upper_bound", "response": {"status_code": 200, "request_id": "cd082f2fc5b5942b220684f75584446f", "body": {"id": "chatcmpl-BTyjkVX79OU9TMYn0f69GURSMBiwe", "object": "chat.completion", "created": 1746484684, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cDiazepam\u2013gastric inflammation\u2013Ofloxacin\u201d indicates that gastric inflammation occurs when Ofloxacin is coadministered with Diazepam. As the fluoroquinolone, Ofloxacin is responsible for this adverse gastrointestinal effect in the presence of the benzodiazepine.  \nANSWER: Ofloxacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 772, "completion_tokens": 341, "total_tokens": 1113, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8293688190a80543a2c22f48e2", "custom_id": "Pamidronic acid-thiotepa_3:upper_bound", "response": {"status_code": 200, "request_id": "a554f53775dd1cb79de7408bc7220870", "body": {"id": "chatcmpl-BTyjudKlywJYJ36GqaVctRogHdytP", "object": "chat.completion", "created": 1746484694, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Pamidronic acid contains a central tertiary alcohol and two phosphonic acid OH groups capable of donating hydrogen bonds, whereas thiotepa\u2019s aziridine nitrogens are tertiary (no N\u2013H) and its P=S group cannot serve as an H-bond donor.  \nANSWER: Pamidronic acid", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 312, "completion_tokens": 788, "total_tokens": 1100, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 704, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a82ca34819083a0ed904a37d2d6", "custom_id": "Cimetidine-Labetalol-Metoprolol-Prostacyclin receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "ad725d941164a069a5b36662d5aa374b", "body": {"id": "chatcmpl-BTykAiV7Y8TJaswd5RUCYQlMIP6CW", "object": "chat.completion", "created": 1746484710, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described drug is metoprolol\u2014 a cardioselective \u03b21-blocker with CYP2D6-dependent metabolism. According to the interaction data, metoprolol binds to and activates the prostacyclin receptor (IP), which mediates potent vasodilation and is clinically targeted in conditions of pathological vasoconstriction.  \nANSWER: Prostacyclin receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1085, "completion_tokens": 290, "total_tokens": 1375, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a82e4c4819086b205658b9c85bc", "custom_id": "Naproxen-Furosemide-Zolpidem-vincristine_5:upper_bound", "response": {"status_code": 200, "request_id": "6d259c26f5fccfd4fa2d683913a62cc8", "body": {"id": "chatcmpl-BTykHkyYLsgmEa3tSVIwSfApETAfI", "object": "chat.completion", "created": 1746484717, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The propionic acid derivative with a methoxy naphthalene motif is Naproxen. It H-bonds to the benzene system bearing a sulfonamide and carboxylic acid, Furosemide. Furosemide H-bonds to the imidazo[1,2-a]pyridine with a tolyl and methylamide substituent, Zolpidem. Zolpidem, in turn, sterically clashes with the multi-ring indole scaffold bearing multiple methoxy groups and an ester side chain, which is vincristine.  \nANSWER: vincristine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 630, "completion_tokens": 1365, "total_tokens": 1995, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1216, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a82ff708190a58fd99dbec45cb6", "custom_id": "Fentanyl-vincristine_3:upper_bound", "response": {"status_code": 200, "request_id": "e8f4a61faa5e6fc40ee534e3ece8ecc5", "body": {"id": "chatcmpl-BTykepZrSJxKqCO17vREaJ2nQ8jcJ", "object": "chat.completion", "created": 1746484740, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described piperidine-phenethyl-anilide structure corresponds to fentanyl, and the bulky fused-ring, methoxycarbonyl/indole framework corresponds to vincristine. The reported interaction is \u201cFentanyl\u2013Steric clash\u2013Vincristine,\u201d indicating that fentanyl will suffer steric hindrance when co-administered with vincristine.  \nANSWER: Fentanyl", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 410, "completion_tokens": 489, "total_tokens": 899, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a831d688190ac186291cc9a02dd", "custom_id": "Diazepam-Temozolomide_3:upper_bound", "response": {"status_code": 200, "request_id": "1df8a8ea60851b1131c5208994086d00", "body": {"id": "chatcmpl-BTykpTuAngfN5jYkzZXEUOLADJoXR", "object": "chat.completion", "created": 1746484751, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Diazepam\u2019s benzodiazepine scaffold is fully N-substituted (no \u2013NH), so it can only serve as a hydrogen\u2010bond acceptor via its carbonyl oxygen. Temozolomide, by contrast, bears an amide (\u2013CONH\u2013) within its imidazotetrazine ring, providing an \u2013NH hydrogen capable of donating a hydrogen bond.ANSWER: Temozolomide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 353, "completion_tokens": 493, "total_tokens": 846, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a833f088190b2c0f99cd494e9f6", "custom_id": "Efavirenz-Lamivudine_0:upper_bound", "response": {"status_code": 200, "request_id": "246cde823a05b24a0ed95feac5dd84af", "body": {"id": "chatcmpl-BTykyDpMORYBj3ncMvXs9Xbb5YLFs", "object": "chat.completion", "created": 1746484760, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Efavirenz is a non-nucleoside reverse transcriptase inhibitor contraindicated in pregnancy for its teratogenic risk. The provided interaction triple (Efavirenz\u2013gastric inflammation\u2013Lamivudine) indicates that efavirenz, when combined with the pregnancy-safe nucleoside analogue lamivudine, has been linked to gastric inflammation.  \nANSWER: Efavirenz", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 711, "completion_tokens": 293, "total_tokens": 1004, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a835ce08190b9ccad5b30b50f0b", "custom_id": "Aciclovir-Azelastine_0:upper_bound", "response": {"status_code": 200, "request_id": "b976900778de6c75b2dd6080c5c2354e", "body": {"id": "chatcmpl-BTyl6wMit6Yu5w7XrrNZDV8CbzU1Q", "object": "chat.completion", "created": 1746484768, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple is formatted as subject-predicate-object: Aciclovir (subject) \u2013 erythema (predicate) \u2013 Azelastine (object). This indicates that when the guanosine analogue antiviral (Aciclovir) is co-administered with the H1 antagonist (Azelastine), it is Aciclovir that is associated with the appearance of erythema.  \nANSWER: Aciclovir", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 629, "completion_tokens": 1074, "total_tokens": 1703, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 960, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a838bfc819085cf486b5ede310a", "custom_id": "indometacin-Terazosin_0:upper_bound", "response": {"status_code": 200, "request_id": "25c2a6e6c203fb5e142aec2d40d22e01", "body": {"id": "chatcmpl-BTylP6leCSLhj07l2So1cDkKtq7Qw", "object": "chat.completion", "created": 1746484787, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cindometacin-erythema-Terazosin\u201d indicates that when indometacin is taken concomitantly with the \u03b1\u2081-blocker terazosin, erythema occurs.  \nANSWER: indometacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 574, "completion_tokens": 328, "total_tokens": 902, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a83a8cc8190aae1aef747a65020", "custom_id": "Ofloxacin-Darunavir_3:upper_bound", "response": {"status_code": 200, "request_id": "c8ae413fad6f453b408a2b5bb6e008a9", "body": {"id": "chatcmpl-BTylUqmPaWacCMRwoWQ3OludirXh3", "object": "chat.completion", "created": 1746484792, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described bicyclic ring system fused to a piperazine moiety, bearing both fluorine and ketone groups, matches the fluoroquinolone scaffold of Ofloxacin. In the given interaction, Ofloxacin forms hydrogen bonds with Darunavir, which contains a sulfonamide-linked phenyl ring and cyclic ether units.  \nANSWER: Ofloxacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 364, "completion_tokens": 413, "total_tokens": 777, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a83c1608190a0ffca7e8db741e9", "custom_id": "Fentanyl-Labetalol_0:upper_bound", "response": {"status_code": 200, "request_id": "312f78dfa9a782c183764731f2c0d87d", "body": {"id": "chatcmpl-BTylifHLtMjN7G8D6znLOaodL1QUC", "object": "chat.completion", "created": 1746484806, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Fentanyl is a synthetic piperidine opioid agonist with exceptionally high \u03bc-opioid receptor affinity and is indicated for severe pain management (e.g., back injury). Labetalol, by contrast, is an \u03b1- and \u03b2-adrenergic blocker used for blood pressure control, not analgesia.  \nANSWER: Fentanyl", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 724, "completion_tokens": 348, "total_tokens": 1072, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a83d9a48190b8bfb831c00ae8f9", "custom_id": "indometacin-Sildenafil_0:upper_bound", "response": {"status_code": 200, "request_id": "c79b7f24197a6838cd988531c7ef6ed7", "body": {"id": "chatcmpl-BTyltb5WdOXnwEIRGL6qhwwpJPI8M", "object": "chat.completion", "created": 1746484817, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a selective phosphodiesterase type 5 (PDE5) inhibitor that enhances nitric oxide\u2013mediated vasodilation and, when combined with an NSAID (indometacin), is linked to apoplexy. That profile matches Sildenafil.  \nANSWER: Sildenafil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 664, "completion_tokens": 271, "total_tokens": 935, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a83fcb0819092f700e9973ad96f", "custom_id": "Citalopram-Propofol_0:upper_bound", "response": {"status_code": 200, "request_id": "966b88f501f99f9925bbfaf6c48ee0cf", "body": {"id": "chatcmpl-BTylywzkZSl448z6EYfraBsjX2wbk", "object": "chat.completion", "created": 1746484822, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple is formatted as subject\u2013predicate\u2013object: \u201cCitalopram\u2013cataract\u2013Propofol.\u201d This indicates that when co-administered with propofol, citalopram is the agent linked to cataract development.  \nANSWER: Citalopram", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 777, "completion_tokens": 850, "total_tokens": 1627, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 768, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8422d48190b87fede5ecea38fe", "custom_id": "Triazolam-Rosiglitazone-Bimatoprost_4:upper_bound", "response": {"status_code": 200, "request_id": "0095208101248294a2fe053fd4759265", "body": {"id": "chatcmpl-BTymIxUU5YGKAeZojd5KCtazIpqXz", "object": "chat.completion", "created": 1746484842, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The described scaffold\u2014a cyclopentane core bearing multiple hydroxyls, an amide-terminated alkyl side chain, phenyl and alkene substituents\u2014matches the structure of Bimatoprost. According to the provided interaction triples, Bimatoprost forms a hydrogen bond with Rosiglitazone, the pyridyl\u2010containing thiazolidinedione that \u03c0\u2013\u03c0 stacks with Triazolam.  \nANSWER: Bimatoprost", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 462, "completion_tokens": 565, "total_tokens": 1027, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a84432c8190b78d868536954c0c", "custom_id": "Naproxen-Gabapentin_0:upper_bound", "response": {"status_code": 200, "request_id": "5b38f9a34f8d8c5f9d13eb5641de639c", "body": {"id": "chatcmpl-BTymR0LxzmoTPqsGwJF8Dlnv2fg6H", "object": "chat.completion", "created": 1746484851, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Gabapentin is the neuropathic pain agent that binds the \u03b12\u03b4-1 subunit of voltage-gated calcium channels. Naproxen is the nonsteroidal anti-inflammatory drug that non-selectively inhibits COX-1 and COX-2, disrupting protective gastric prostaglandin synthesis and thereby increasing the risk of gastric inflammation when used concomitantly.  \nANSWER: Naproxen", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 773, "completion_tokens": 364, "total_tokens": 1137, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8465d48190938d0a89d13ef1a2", "custom_id": "Duloxetine-Desloratadine_3:upper_bound", "response": {"status_code": 200, "request_id": "c79524364227bb2b2247ff23a7017225", "body": {"id": "chatcmpl-BTymXz99DDei908Riyqr6tjtY4M0A", "object": "chat.completion", "created": 1746484857, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Duloxetine contains an electron\u2010rich thiophene ring linked via an ether to a fused naphthalene system, making its aromatic surfaces more donating in \u03c0\u2013\u03c0 interactions. Desloratadine\u2019s tricyclic chlorinated ring is electron\u2010withdrawing and thus acts as the acceptor.  \nANSWER: Duloxetine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 345, "completion_tokens": 599, "total_tokens": 944, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a847b58819088091acb629a96bd", "custom_id": "Loxapine-Muscarinic acetylcholine receptor M4_6:upper_bound", "response": {"status_code": 200, "request_id": "630dd6996f0fff84c0ef5436745e6faf", "body": {"id": "chatcmpl-BTyjEaYbkhe7WvqdObTTiYJnMWOPx", "object": "chat.completion", "created": 1746484652, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The CHRM4 gene encodes the muscarinic acetylcholine receptor M4, a cholinergic receptor subtype. Loxapine, a tricyclic antipsychotic structurally similar to clozapine and used in schizophrenia, binds to and inhibits this receptor.  \nANSWER: Muscarinic acetylcholine receptor M4", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 453, "completion_tokens": 220, "total_tokens": 673, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8496948190a887e913826c032c", "custom_id": "indometacin-vincristine-Torasemide_1:upper_bound", "response": {"status_code": 200, "request_id": "b99f70efbdc998b6f10855e42178d2fe", "body": {"id": "chatcmpl-BTyjLAl2ACOCkh5rYh0UsyCqUlBpW", "object": "chat.completion", "created": 1746484659, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The vinca alkaloid described is vincristine, which when co-administered with the sulfonamide loop diuretic torasemide increases the risk of nonspecific drug toxicity.  \r\nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 934, "completion_tokens": 260, "total_tokens": 1194, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a84b33c8190baaeaf5510b7e8df", "custom_id": "Cimetidine-Duloxetine_3:upper_bound", "response": {"status_code": 200, "request_id": "5bcf31282d70ea5016b0e487347fe58c", "body": {"id": "chatcmpl-BTyjQQICtJszkt8oJdhI2aJGSBuQk", "object": "chat.completion", "created": 1746484664, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The description \u201cimidazole ring substituted with sulfur and cyano functionalities\u201d matches cimetidine\u2019s core (an imidazole bearing a thioether side chain and a \u2013C\u2261N group). Its partner, \u201ca molecule that features a thiophene ring and an ether linkage between aromatic systems,\u201d is duloxetine. According to the provided interaction, cimetidine forms hydrogen bonds with duloxetine.  \nANSWER: Cimetidine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 306, "completion_tokens": 430, "total_tokens": 736, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a84ce048190a587017d78c6488a", "custom_id": "Amlodipine-Metolazone-Metoprolol-Gastrin-releasing peptide receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "d19e475294eb28a4d8df4784e6a3c192", "body": {"id": "chatcmpl-BTyjcYQnW7mfLdnwcnAdcFoB4aWuV", "object": "chat.completion", "created": 1746484676, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question refers to a G protein\u2013coupled receptor that is highly expressed in the pancreas, mediates gastrointestinal hormone release and smooth muscle contraction, and is directly bound and activated by metoprolol\u2014a cardioselective \u03b21-adrenergic antagonist often co-prescribed with the thiazide-like diuretic metolazone. According to the interaction data, metoprolol binds and activates the gastrin-releasing peptide receptor, which matches the described functions.  \nANSWER: Gastrin-releasing peptide receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1187, "completion_tokens": 322, "total_tokens": 1509, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a84eb9c8190a85910cb7c60de88", "custom_id": "Gabapentin-Ibuprofen_0:upper_bound", "response": {"status_code": 200, "request_id": "a558c216e80409d1b9d5bee5ed0ec241", "body": {"id": "chatcmpl-BTyjkwqcRcid5SIfdvwVIh1r0M567", "object": "chat.completion", "created": 1746484684, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug described as a voltage-gated calcium channel modulator for neuropathic pain and seizure disorders is gabapentin. The provided interaction triple (Gabapentin-erythema-Ibuprofen) indicates that when gabapentin is combined with the COX-inhibitor ibuprofen, there is an enhanced risk of erythema.  \nANSWER: Gabapentin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 751, "completion_tokens": 290, "total_tokens": 1041, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a850d5481908ee9b83bcf1a4132", "custom_id": "Furosemide-Salmeterol_3:upper_bound", "response": {"status_code": 200, "request_id": "68b5725d36f7d1dc6b67b7fdf38aa7b6", "body": {"id": "chatcmpl-BTyjqfo6k3oFA4eROAPCrqqQ4rwUs", "object": "chat.completion", "created": 1746484690, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Furosemide bears both a carboxylic\u2010acid OH and a sulfonamide NH, each capable of donating hydrogen bonds to acceptor atoms in salmeterol\u2019s ether or phenolic oxygens. Salmeterol, by contrast, primarily offers its hydroxyls and secondary amine as donors but in the reported interaction Furosemide supplies the hydrogen.  \nANSWER: Furosemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 372, "completion_tokens": 1000, "total_tokens": 1372, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 896, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a852e8c819098af4a8ee7aba481", "custom_id": "Amlodipine-Sufentanil_0:upper_bound", "response": {"status_code": 200, "request_id": "3b69fe3fc2ba5b9a52db7d37d6908fd7", "body": {"id": "chatcmpl-BTykB2tIz7US2Ii2d7WnwDukshPa8", "object": "chat.completion", "created": 1746484711, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The long-acting dihydropyridine calcium channel blocker in question is amlodipine, and the only ultra-potent synthetic opioid analgesic provided is sufentanil. The specified drug\u2013drug interaction triple (Amlodipine \u2192 right heart failure \u2190 Sufentanil) identifies sufentanil as the co-administered opioid that may elevate the risk of right heart failure.  \nANSWER: Sufentanil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 562, "completion_tokens": 431, "total_tokens": 993, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8551f08190a5d64d6100af3e94", "custom_id": "Fentanyl-Trimethoprim_0:upper_bound", "response": {"status_code": 200, "request_id": "5909ec6ae4e9aa4fdf053e6f28b6f3c4", "body": {"id": "chatcmpl-BTykL2F7BDsAMK3pLhsKTdJMgCaEB", "object": "chat.completion", "created": 1746484721, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cFentanyl-dysarthria-Trimethoprim\u201d links fentanyl with the antibiotic that blocks bacterial folate metabolism and is used for bladder and ear infections. The adverse event dysarthria in this context implicates Trimethoprim.  \nANSWER: Trimethoprim", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 719, "completion_tokens": 276, "total_tokens": 995, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8572bc8190a93deab978bf4dcb", "custom_id": "Tolbutamide-Perindopril_0:upper_bound", "response": {"status_code": 200, "request_id": "dc4f6508eb75705e1415bb3a4ed260c9", "body": {"id": "chatcmpl-BTykSKlfj1lwqR5Gc3K77EAJIjBkj", "object": "chat.completion", "created": 1746484728, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes an ACE inhibitor that lowers blood pressure by blocking angiotensin II synthesis and, in combination with the sulfonylurea tolbutamide, is linked to muscle disorders. According to the provided interaction triple (Tolbutamide\u2013muscle disorder\u2013Perindopril), the drug in question is Perindopril.  \nANSWER: Perindopril", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 599, "completion_tokens": 289, "total_tokens": 888, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a858f588190b74b9f1fe70456c4", "custom_id": "Naproxen-Lamotrigine_3:upper_bound", "response": {"status_code": 200, "request_id": "b9d94d4a39232e66b231e3c3bc951986", "body": {"id": "chatcmpl-BTyka2k8GlNYhwnXz3RlT1GaDwyKE", "object": "chat.completion", "created": 1746484736, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Naproxen contains a carboxylic acid (\u2013COOH) whose hydroxyl hydrogen can serve as a hydrogen\u2010bond donor, whereas lamotrigine\u2019s dichlorotriazine ring amines are primarily hydrogen\u2010bond acceptors in this interaction.  \nANSWER: Naproxen", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 344, "completion_tokens": 466, "total_tokens": 810, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a85ac548190b214c33837f3d66c", "custom_id": "Ibuprofen-desvenlafaxine_3:upper_bound", "response": {"status_code": 200, "request_id": "24a4cb429242749513cf74e19662624c", "body": {"id": "chatcmpl-BTykld5XRIGJJqBRfH5cohjp58XOd", "object": "chat.completion", "created": 1746484747, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Hydrogen bond acceptors are typically lone\u2010pair\u2013bearing heteroatoms that are not heavily involved in intramolecular hydrogen bonds. Although ibuprofen\u2019s carboxylate oxygen can accept H\u2010bonds, desvenlafaxine presents a tertiary amine nitrogen plus phenolic and cyclohexanol oxygens, all of which are strong lone\u2010pair donors for hydrogen bonding and are not sequestered by intramolecular H\u2010bonding. Thus desvenlafaxine is the more likely H\u2010bond acceptor.  \nANSWER: desvenlafaxine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 338, "completion_tokens": 841, "total_tokens": 1179, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 704, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a85dfd881909f083b48c20d0a20", "custom_id": "Candesartan-Citalopram_3:upper_bound", "response": {"status_code": 200, "request_id": "0c24ab09aa476af5e81ab7c6908372e0", "body": {"id": "chatcmpl-BTyl09n0KyOrBowdxgfqFM8BP4GiJ", "object": "chat.completion", "created": 1746484762, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple specifies Candesartan-\u03c0-\u03c0 Stacking-Citalopram, indicating that the biphenyl-tetrazole\u2013containing molecule (Candesartan) engages in \u03c0-\u03c0 stacking with the phthalane-nitrile-fluorophenyl\u2013bearing molecule.  \nANSWER: Candesartan", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 357, "completion_tokens": 538, "total_tokens": 895, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a85f8bc81909f6c8b0b56d84c33", "custom_id": "Amlodipine-Exemestane_0:upper_bound", "response": {"status_code": 200, "request_id": "1baf771ebb9cfa32611056260c85fae9", "body": {"id": "chatcmpl-BTylCU8bDHkYy64oSCrLgtx0GOZIE", "object": "chat.completion", "created": 1746484774, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a globally recognized antihypertensive agent that blocks L-type calcium channels. The provided interaction triple (Amlodipine\u2013Pain\u2013Exemestane) indicates this calcium channel blocker induces pain when coadministered with the aromatase inhibitor exemestane.  \nANSWER: Amlodipine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 542, "completion_tokens": 345, "total_tokens": 887, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8615048190884395ac65084ee5", "custom_id": "Ofloxacin-Imatinib_3:upper_bound", "response": {"status_code": 200, "request_id": "bda3e0d28c61a0a9b0987d20d08ae2f3", "body": {"id": "chatcmpl-BTylKPy8Ln6lrcK2RmTkZrmMOhXdB", "object": "chat.completion", "created": 1746484782, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The description \u201cpiperazinyl-substituted quinolone carboxylic acid core with a fluorinated bicyclic aromatic system\u201d matches Ofloxacin, which is noted to form hydrogen bonds with the phenylaminopyrimidine-containing drug.  \nANSWER: Ofloxacin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 375, "completion_tokens": 271, "total_tokens": 646, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8628a08190be6090bab88ba87d", "custom_id": "Labetalol-Beta-3 adrenergic receptor_6:upper_bound", "response": {"status_code": 200, "request_id": "6848f5126f724d5d1c577a01e88e16ab", "body": {"id": "chatcmpl-BTylPVkIQ6JpjoS9Gorj4uzutWbYx", "object": "chat.completion", "created": 1746484787, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Labetalol is a nonselective \u03b2- and \u03b1-adrenergic blocker used for hypertension and angina. The ADRB3 gene encodes the \u03b23-adrenoceptor, which is one of the \u03b2-adrenergic receptors that labetalol binds to and inhibits.  \nANSWER: Beta-3 adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 512, "completion_tokens": 219, "total_tokens": 731, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a86434881909fda6755871a8f3c", "custom_id": "Cimetidine-Histamine H2 receptor_6:upper_bound", "response": {"status_code": 200, "request_id": "3a8a6bfdfdb77940da9b31a0fd7ffa13", "body": {"id": "chatcmpl-BTylUD65kZYbFHQcaeGdczmPFrdhJ", "object": "chat.completion", "created": 1746484792, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a receptor that is positively coupled to adenylate cyclase via the Gs alpha subunit and stimulates cAMP production. Cimetidine, an H2-receptor antagonist used to reduce stomach acid in heartburn and peptic ulcer treatment, binds to and inhibits this receptor.  \nANSWER: Histamine H2 receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 507, "completion_tokens": 218, "total_tokens": 725, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a865c58819084f8d0c05bb24040", "custom_id": "chlortalidone-Sildenafil-Zaleplon_1:upper_bound", "response": {"status_code": 200, "request_id": "ada1a9fab937e3643f785de22add494e", "body": {"id": "chatcmpl-BTyleka0A55FWFKaEs1PaCXJFVd3T", "object": "chat.completion", "created": 1746484802, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cSildenafil-apoplexy-Zaleplon\u201d identifies the sedative-hypnotic involved in the adverse effect with the PDE5 inhibitor sildenafil as the nonbenzodiazepine pyrazolopyrimidine Z-drug.  \nANSWER: Zaleplon", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 947, "completion_tokens": 273, "total_tokens": 1220, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a867abc819081a51e67c0242c75", "custom_id": "Cimetidine-Sumatriptan-Balsalazide_1:upper_bound", "response": {"status_code": 200, "request_id": "5ef03ba0a164757f5867180bde01f4e2", "body": {"id": "chatcmpl-BTyljmIRCLlzGdQ8jICgUZDMvBlNr", "object": "chat.completion", "created": 1746484807, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug described is a disease-modifying antirheumatic agent that delivers 5-aminosalicylic acid to the large intestine for inflammatory bowel disease\u2014this matches balsalazide. The provided interaction triple \u201cSumatriptan-Difficulty breathing-Balsalazide\u201d confirms that concomitant use with the 5-HT1B/1D agonist sumatriptan can cause difficulty breathing.  \nANSWER: Balsalazide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 902, "completion_tokens": 370, "total_tokens": 1272, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a869484819084ae444262febb75", "custom_id": "Cimetidine-Labetalol-Alpha-1D adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "49a5cc559f8ea1046da8a3086a429490", "body": {"id": "chatcmpl-BTylqsCEx6KSR9YvLI0KM5yQSKssx", "object": "chat.completion", "created": 1746484814, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Labetalol is described as blocking both \u03b2- and \u03b1-adrenergic receptors, and the provided drug\u2013protein interaction triple specifies that labetalol binds to and inhibits the Alpha-1D adrenergic receptor.  \nANSWER: Alpha-1D adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 710, "completion_tokens": 271, "total_tokens": 981, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a86b30c8190be3c5684f800a81f", "custom_id": "Famotidine-Ticlopidine_3:upper_bound", "response": {"status_code": 200, "request_id": "0ec3502b0ff0c53bc4e02064471472d3", "body": {"id": "chatcmpl-BTylxrwfXBDH5tiebWzdDh72SDVqB", "object": "chat.completion", "created": 1746484821, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Famotidine\u2019s structure features a thiazole ring fused to a guanidine moiety and a sulfonamide group, making it capable of serving as a hydrogen-bond donor or acceptor in its interaction with the thienopyridine-containing, chlorobenzene-substituted ticlopidine.  \nANSWER: Famotidine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 331, "completion_tokens": 478, "total_tokens": 809, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a86d07081908531403811a751b4", "custom_id": "Naproxen-Cetirizine-Salmeterol_4:upper_bound", "response": {"status_code": 200, "request_id": "7b954ba23d6e1ee7e55611c2c2f6beec", "body": {"id": "chatcmpl-BTyjMAj4qX8G2fHC5xs1123LVt3BX", "object": "chat.completion", "created": 1746484660, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: In the Naproxen\u2013Cetirizine interaction (Naproxen-Hydrogen Bond-Cetirizine), the carbonyl oxygen of Naproxen\u2019s carboxylate serves as the hydrogen\u2010bond acceptor for the piperazine unit of Cetirizine.  \r\nANSWER: Naproxen", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 464, "completion_tokens": 2648, "total_tokens": 3112, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2560, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a86ee9881909599659d2ecd77a0", "custom_id": "phenytoin-Dapsone-Pyrimethamine-Muscarinic acetylcholine receptor M1_8:upper_bound", "response": {"status_code": 200, "request_id": "e248a942aaa9fe365e2d28cc507e9e57", "body": {"id": "chatcmpl-BTyk8iz0hqTdXipLABljz1k5HDJ8p", "object": "chat.completion", "created": 1746484708, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The folic acid antagonist among the three drugs is pyrimethamine, which according to the provided interaction triple binds to and inhibits a neural cell-surface receptor found predominantly in the CNS and exocrine glands that is Gq-coupled. This receptor is the muscarinic acetylcholine receptor M1.  \nANSWER: Muscarinic acetylcholine receptor M1", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1360, "completion_tokens": 418, "total_tokens": 1778, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a87091c8190bbd1b1cfc7bf8773", "custom_id": "Ziprasidone-Desloratadine-Telithromycin_1:upper_bound", "response": {"status_code": 200, "request_id": "dcadac86c4bd7989892cd16df1fe0676", "body": {"id": "chatcmpl-BTykIEwWoZkJ8sK8Hef9039ZthkYz", "object": "chat.completion", "created": 1746484718, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The provided interaction triple \u201cDesloratadine\u2013Sinus headache\u2013Telithromycin\u201d indicates that when the ketolide antibiotic telithromycin is added to desloratadine, there is an increased risk of sinus headache.  \nANSWER: Telithromycin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 867, "completion_tokens": 266, "total_tokens": 1133, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8731f08190b8232a2d1b703fa7", "custom_id": "Naproxen-Carvedilol_3:upper_bound", "response": {"status_code": 200, "request_id": "5856a40dbde88fa3514fd73ed54181ca", "body": {"id": "chatcmpl-BTykNTAHNzGR20do3Fk0wEc9jdpM4", "object": "chat.completion", "created": 1746484723, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Carvedilol\u2019s secondary alcohol group serves as the hydrogen-bond donor, while the carbonyl oxygen of Naproxen\u2019s carboxylate functions as the hydrogen-bond acceptor.  \nANSWER: Naproxen", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 360, "completion_tokens": 1091, "total_tokens": 1451, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1024, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a874e0481909652cb3a50f33137", "custom_id": "Candesartan-mitomycin C-vincristine-Torasemide_5:upper_bound", "response": {"status_code": 200, "request_id": "af69b00b6ceafc3ebdc7acda4aa794ef", "body": {"id": "chatcmpl-BTykhLzW4O5vgeHHv21ZYIC1UevCV", "object": "chat.completion", "created": 1746484743, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The only alkaloid here containing both an indole and a catharanthine moiety is vincristine (Drug 3). In the provided interaction chain, vincristine donates a hydrogen bond to Drug 4. Drug 4\u2019s structure features a chlorobenzenesulfonamide group on a pyridine ring plus a urea linkage\u2014this matches Torasemide.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 599, "completion_tokens": 812, "total_tokens": 1411, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 704, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a876aec8190b25ce6f229ab08bd", "custom_id": "Gabapentin-Amiloride_0:upper_bound", "response": {"status_code": 200, "request_id": "243fa227da5fec78caeaffab5e588c88", "body": {"id": "chatcmpl-BTykw3fVx9PgcRmix046iOu9ENCIk", "object": "chat.completion", "created": 1746484758, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Of the two agents, gabapentin is known to cause peripheral edema and weight gain as adverse effects. The reported interaction \u201cGabapentin\u2013weight gain\u2013Amiloride\u201d indicates that when gabapentin is co-administered with amiloride, weight gain is observed. Amiloride, a potassium-sparing diuretic, does not typically produce weight gain.  \nANSWER: Gabapentin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 699, "completion_tokens": 618, "total_tokens": 1317, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a87995c8190832eb23cc0ed8991", "custom_id": "Fentanyl-Trazodone_3:upper_bound", "response": {"status_code": 200, "request_id": "07586ddb40fcced2f90ce2523db8096f", "body": {"id": "chatcmpl-BTyl75US9DZm1bI36B1W93BSJJOaT", "object": "chat.completion", "created": 1746484769, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Fentanyl bears a tertiary amide (the propionyl carbonyl) that has a lone\u2010pair oxygen capable of accepting a hydrogen bond, whereas trazodone\u2019s nitrogens are fully substituted and cannot serve as donors in this pairing.  \nANSWER: Fentanyl", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 356, "completion_tokens": 1294, "total_tokens": 1650, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1216, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a87c0808190b88067e8b7a5141f", "custom_id": "Lidocaine-vincristine-Torasemide_4:upper_bound", "response": {"status_code": 200, "request_id": "5a5868954f621ad2716aa83257ac5e2d", "body": {"id": "chatcmpl-BTylThcmpV3MRfGCpFmx2sbQJJDTR", "object": "chat.completion", "created": 1746484791, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug with a methylated aniline core linked to a sulfonylurea moiety and a phenyl ring fused to a pyridine is Torasemide (Drug 3). According to the interaction data, vincristine (the bis-indole alkaloid) forms a hydrogen bond with Torasemide. Lidocaine (the acylated aromatic amide with a diethylaminoethyl side chain) also hydrogen-bonds with vincristine, confirming vincristine\u2019s role as the common interaction partner.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 492, "completion_tokens": 584, "total_tokens": 1076, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a87deac8190bd1e9fba2e40c213", "custom_id": "Carvedilol-Dobutamine_0:upper_bound", "response": {"status_code": 200, "request_id": "b25ec1c0bf3842458a7f2fcf48b787f4", "body": {"id": "chatcmpl-BTylkz2NjrTDIbwWzjX6zZMpiLp07", "object": "chat.completion", "created": 1746484808, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The nonselective \u03b2-adrenergic blocker with \u03b1\u2081-antagonism used in HFrEF that interacts (via a hepatitis-related mechanism) when co-administered with a synthetic \u03b2\u2081-agonist in short-term inotropic support is carvedilol.  \nANSWER: Carvedilol", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 679, "completion_tokens": 280, "total_tokens": 959, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a87fba081909c33c03daa9df394", "custom_id": "Citalopram-Zolpidem_0:upper_bound", "response": {"status_code": 200, "request_id": "8d15a8d1d358bf83d14f59c4724e43ff", "body": {"id": "chatcmpl-BTylqdcwsVMiny4wUA7lFgbMLe3F2", "object": "chat.completion", "created": 1746484814, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The SSRI described is citalopram, and the nonbenzodiazepine Z-drug acting as a GABAA receptor modulator for short-term insomnia is zolpidem.  \nANSWER: Zolpidem", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 859, "completion_tokens": 324, "total_tokens": 1183, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a881ba481909e679387acf93fa7", "custom_id": "Fentanyl-Labetalol-Alpha-2A adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "df3ebb44739c8d3a6d44d1d7057c3bb9", "body": {"id": "chatcmpl-BTylxrtGtgpKWnEW0WNhUIwSxJqcR", "object": "chat.completion", "created": 1746484821, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Labetalol is an antihypertensive that blocks both \u03b2- and \u03b1-adrenergic receptors. According to the provided interaction data, it binds to and inhibits the alpha-2A adrenergic receptor.  \nANSWER: Alpha-2A adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 847, "completion_tokens": 206, "total_tokens": 1053, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a88344c8190a9f7357447acde70", "custom_id": "Fluorouracil-Fulvestrant_3:upper_bound", "response": {"status_code": 200, "request_id": "9a06f5b743d77125b2bc74ce5c3f3967", "body": {"id": "chatcmpl-BTym19L6YW6ADfcAJ0jjnSCOrrYcB", "object": "chat.completion", "created": 1746484825, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Fluorouracil\u2019s pyrimidine ring bears two NH moieties (an amide\u2010like N\u2013H adjacent to carbonyls), which are stronger and more numerous hydrogen\u2010bond donors than Fulvestrant\u2019s single phenolic OH. These imide/amide N\u2013H groups thus serve as the primary H-bond donors in the interaction.  \nANSWER: Fluorouracil", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 347, "completion_tokens": 615, "total_tokens": 962, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a88531c81909eed27be8ae0e4dc", "custom_id": "Zolpidem-vincristine_3:upper_bound", "response": {"status_code": 200, "request_id": "a883f03acc3e7289af080574da884840", "body": {"id": "chatcmpl-BTymB00n8YbXRl3RDnTmc8gzwaIWb", "object": "chat.completion", "created": 1746484835, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The fused imidazopyridine core with a para-substituted toluene ring describes zolpidem, and the reported interaction \u201cZolpidem \u2013 Steric Clashes \u2013 vincristine\u201d indicates that zolpidem is the one experiencing steric clashes when co-administered.  \nANSWER: Zolpidem", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 417, "completion_tokens": 415, "total_tokens": 832, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8870c48190a600fcecba48bdf3", "custom_id": "Cimetidine-hydroxychloroquine_3:upper_bound", "response": {"status_code": 200, "request_id": "d740a83402b5ae7f4660aae1a434810e", "body": {"id": "chatcmpl-BTymHrN0svAU1wODHtFPXYvtsLoC2", "object": "chat.completion", "created": 1746484841, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug with a quinoline core bearing a chlorine atom and ending in an \u2013CCO (ethanol) moiety is hydroxychloroquine, which provides H-bond acceptor sites (the quinoline nitrogen and the terminal hydroxyl oxygen) for the guanidine/cyano\u2013containing H\u2082-antagonist cimetidine.  \nANSWER: hydroxychloroquine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 320, "completion_tokens": 420, "total_tokens": 740, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a889540819088de78abc79b7ff1", "custom_id": "Naproxen-Zolpidem-vincristine-Torasemide_5:upper_bound", "response": {"status_code": 200, "request_id": "40243f2bb22245781d3953004421e6d1", "body": {"id": "chatcmpl-BTymO2UXokfoh7wjpumSZ9P8toiVa", "object": "chat.completion", "created": 1746484848, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Torasemide (Drug 4) features a phenyl-substituted pyridine core bearing a sulfonylurea moiety. It is listed in the background as forming hydrogen bonds with vincristine, which contains multiple indole and catharanthine ring systems.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 561, "completion_tokens": 340, "total_tokens": 901, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a88b9b8819084ae3d90c3d939e8", "custom_id": "Citalopram-Isoniazid-Emtricitabine_4:upper_bound", "response": {"status_code": 200, "request_id": "0f5aab8b76ecc752a1863793449c620a", "body": {"id": "chatcmpl-BTymXXTBKf3oVlPH1fEUeQdY5tINK", "object": "chat.completion", "created": 1746484857, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The compound with a sulfur\u2010containing oxathiolane ring linked to a fluorinated pyrimidine base is Emtricitabine. According to the interaction triples, Isoniazid (the hydrazide\u2010substituted pyridine) hydrogen bonds both with Citalopram (the aryloxy tertiary amine with nitrile and fluorobenzene) and with Emtricitabine.  \nANSWER: Emtricitabine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 429, "completion_tokens": 754, "total_tokens": 1183, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 640, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a88daa481909a19ce843e1738ae", "custom_id": "Carbachol-Muscarinic acetylcholine receptor M5_6:upper_bound", "response": {"status_code": 200, "request_id": "fb673a7207cdd7171c54e319ae7486e0", "body": {"id": "chatcmpl-BTymsZNvFUXvNZJZqNqoJgVaXqvNg", "object": "chat.completion", "created": 1746484878, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Carbachol is a cholinomimetic drug used as an ophthalmic solution that mimics acetylcholine and, in overdose, behaves like a nerve agent. The provided interaction triple shows that Carbachol binds to and activates the Muscarinic acetylcholine receptor M5, which is a G protein\u2013coupled receptor (Gq-coupled) primarily expressed in the nervous system.  \nANSWER: Muscarinic acetylcholine receptor M5", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 615, "completion_tokens": 306, "total_tokens": 921, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a88ff6c8190aff2622175130d4d", "custom_id": "acetazolamide-Haloperidol-Rosiglitazone-Bimatoprost_2:upper_bound", "response": {"status_code": 200, "request_id": "ffccb087293330589f6d48f5a298c516", "body": {"id": "chatcmpl-BTyn1u1JGuOUBCEurZLYMB9nZZrYy", "object": "chat.completion", "created": 1746484887, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The PPAR\u03b3 agonist for Type 2 diabetes mellitus is rosiglitazone. The ophthalmic agent described (used when first-line glaucoma treatments are insufficient, increases eyelash growth, and can cause red or dry eyes) is bimatoprost. The provided interaction triple (Rosiglitazone-Adenopathy-Bimatoprost) indicates bimatoprost can interact with rosiglitazone to increase the risk of adenopathy.  \nANSWER: Bimatoprost", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1282, "completion_tokens": 315, "total_tokens": 1597, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a89219881909b9bf77d7058bd57", "custom_id": "Naproxen-alendronic acid_0:upper_bound", "response": {"status_code": 200, "request_id": "f941fd67af171320005f489ef43886e7", "body": {"id": "chatcmpl-BTynBFy6t4t4mbPCAU3MPLGT4kXYO", "object": "chat.completion", "created": 1746484897, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Naproxen is a nonsteroidal anti-inflammatory drug that non-selectively inhibits COX enzymes to reduce prostaglandin synthesis, providing pain and inflammation relief. COX inhibition also compromises gastric mucosal protection, and when combined with a bisphosphonate like alendronic acid\u2014which itself can irritate the gastrointestinal tract\u2014there is a heightened risk of gastric inflammation.  \nANSWER: Naproxen", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 695, "completion_tokens": 299, "total_tokens": 994, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8941b8819095de996a5c59f88e", "custom_id": "Aciclovir-Doxazosin-Alpha-1B adrenergic receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "7aef9f0be1b2c1a9f5df26c1feae0968", "body": {"id": "chatcmpl-BTynFVVSRveCPGNTQ3nlyKoXEcyps", "object": "chat.completion", "created": 1746484901, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Doxazosin is a quinazoline\u2010class \u03b11\u2010adrenergic blocker whose antihypertensive and prostatic effects arise from binding to and inhibiting the \u03b11B\u2010adrenergic receptor, whose crystal structure with an inverse agonist has been solved and which is encoded by the ADRA1B gene.  \nANSWER: Alpha-1B adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 806, "completion_tokens": 356, "total_tokens": 1162, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a895ac08190a3678f30acfe5ba1", "custom_id": "Risedronic acid-Zolpidem_3:upper_bound", "response": {"status_code": 200, "request_id": "ec6ea85a779c50d3322f57816eebb609", "body": {"id": "chatcmpl-BTyjNAmATg3kh6oac5zPAS692AsqE", "object": "chat.completion", "created": 1746484661, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Risedronic acid\u2019s two phosphonic acid moieties feature multiple P\u2013OH groups (excellent hydrogen\u2010bond donors) and P=O oxygens (strong acceptors). In contrast, Zolpidem\u2019s imidazo[1,2-a]pyridine core with a single terminal amide offers only one C=O acceptor and limited N\u2013H donation. Thus the phosphonic acid\u2013rich molecule is far more capable of forming hydrogen bonds with Zolpidem.  \nANSWER: Risedronic acid", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 365, "completion_tokens": 513, "total_tokens": 878, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a89777c8190a41b31ce46f9bffc", "custom_id": "Amlodipine-vincristine_0:upper_bound", "response": {"status_code": 200, "request_id": "3ecca0701407269f3f62ec6b424648bd", "body": {"id": "chatcmpl-BTyjXhOPxZcQdYNzPbr1ysOj8YL2b", "object": "chat.completion", "created": 1746484671, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes a microtubule\u2010disrupting cancer drug with neurotoxic side effects whose white blood cell count is increased when given alongside a dihydropyridine calcium channel blocker (amlodipine). This matches vincristine.  \nANSWER: vincristine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 655, "completion_tokens": 271, "total_tokens": 926, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8996808190a949706fab749de4", "custom_id": "Temazepam-Trimipramine-Histamine H1 receptor_7:upper_bound", "response": {"status_code": 200, "request_id": "eee1c20f7ee7c53d08ad51bf85d9a5d9", "body": {"id": "chatcmpl-BTyjd9Ibib53JBARks93MSW1ihTtM", "object": "chat.completion", "created": 1746484677, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Trimipramine is an atypical tricyclic antidepressant with strong antihistamine activity. The provided interaction triple specifies that Trimipramine binds to and inhibits the Histamine H1 receptor, a G-protein\u2013coupled receptor expressed in smooth muscle, vascular endothelium, and the CNS involved in allergy responses.  \nANSWER: Histamine H1 receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 943, "completion_tokens": 417, "total_tokens": 1360, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a89b5408190b2b2719839bb9ad9", "custom_id": "Naproxen-Risedronic acid-vincristine-Torasemide_2:upper_bound", "response": {"status_code": 200, "request_id": "6134679ecd6a5246e7ef080320850386", "body": {"id": "chatcmpl-BTyjlU4vQxnareIjonKxzxfaPaolG", "object": "chat.completion", "created": 1746484685, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The patient is on intravenous vincristine, a vinca alkaloid, and begins a sulfonamide loop diuretic for fluid overload. The provided interaction data shows a vincristine\u2013Torasemide pair linked by \u201cdrug toxicity NOS,\u201d indicating torasemide can increase vincristine\u2019s toxicity risk.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1170, "completion_tokens": 285, "total_tokens": 1455, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a89d7008190b19b5f4273f8cb5a", "custom_id": "Duloxetine-desvenlafaxine_3:upper_bound", "response": {"status_code": 200, "request_id": "6ca0ed6026885147f55a3c9a4dfbb4f2", "body": {"id": "chatcmpl-BTyjs3FcDEJfffceNlMwZFs9ELZ53", "object": "chat.completion", "created": 1746484692, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Desvenlafaxine carries both a phenolic OH and a cyclohexanol OH, making it the principal source of hydrogen\u2010bond donors in the interaction, whereas duloxetine contributes mainly acceptor sites (ether oxygen, aromatic sulfur) and only a single, less acidic N\u2013H.  \nANSWER: desvenlafaxine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 345, "completion_tokens": 1753, "total_tokens": 2098, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1664, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a89eea88190878d8a75ddb0c388", "custom_id": "Aciclovir-Dipyridamole_0:upper_bound", "response": {"status_code": 200, "request_id": "4ff988103e6d88d3f98e84ff9d5e505c", "body": {"id": "chatcmpl-BTykREn5jqldODRtS7fyWyRcVDAXw", "object": "chat.completion", "created": 1746484727, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug described as an antiviral against herpesviruses with common gastrointestinal side effects that, in interaction with a nucleoside\u2010transport/PDE3 inhibitor (dipyridamole), can lead to skin eruptions is Aciclovir.  \nANSWER: Aciclovir", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 509, "completion_tokens": 462, "total_tokens": 971, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8a07d081909a114454c6846c87", "custom_id": "Celecoxib-Palonosetron_0:upper_bound", "response": {"status_code": 200, "request_id": "03d0cba6f0800580556f774a688cb06a", "body": {"id": "chatcmpl-BTykctYUPLeLyTsr5FJ3XnmzLGrDR", "object": "chat.completion", "created": 1746484738, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question refers to a selective COX-2 inhibitor that, when used alongside a 5-HT3 antagonist for chemotherapy-induced nausea and vomiting, has been linked to a higher incidence of cellulitis. The background data identify celecoxib as the COX-2 inhibitor and palonosetron as the 5-HT3 antagonist, with the drug\u2013drug interaction noted as \u201cCelecoxib\u2013cellulitis\u2013Palonosetron.\u201d\n\nANSWER: Celecoxib", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 705, "completion_tokens": 246, "total_tokens": 951, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8a24088190a47fcb3d194faf35", "custom_id": "Methylphenidate-Modafinil-Pamidronic acid-thiotepa_5:upper_bound", "response": {"status_code": 200, "request_id": "644bd0264a1535b59ebe077d0082c3df", "body": {"id": "chatcmpl-BTyki2Pmf75suD7dMNPagzdOdwu3A", "object": "chat.completion", "created": 1746484744, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The description traces the interaction chain: Methylphenidate (a piperidinyl phenyl ester) \u03c0\u2013\u03c0 stacks with Modafinil (sulfinyl-containing), which hydrogen bonds to Pamidronic acid (two phosphonic acids and a primary amine), which in turn hydrogen bonds to ThioTEPA (contains a phosphorothioate and three aziridine rings around phosphorus).  \nANSWER: thiotepa", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 498, "completion_tokens": 367, "total_tokens": 865, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8a3c748190809f649402d72a60", "custom_id": "Desloratadine-solifenacin_0:upper_bound", "response": {"status_code": 200, "request_id": "a1002d9455e0ea9207c1f852484f03f5", "body": {"id": "chatcmpl-BTykqiECTT7R2KsYMyVvkXG3haWHw", "object": "chat.completion", "created": 1746484752, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cDesloratadine-bursitis-solifenacin\u201d indicates that Desloratadine (the tricyclic H1 inverse agonist) is the drug associated with bursitis when interacting with solifenacin.  \nANSWER: Desloratadine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 542, "completion_tokens": 461, "total_tokens": 1003, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8a52a08190bbb84b5bfa7064a2", "custom_id": "Naproxen-hydroxychloroquine_3:upper_bound", "response": {"status_code": 200, "request_id": "156773049f2fc2bedbe7cbf53df17fac", "body": {"id": "chatcmpl-BTyl0ZI1EFX7aSCUtWJ3hX1d0vnz7", "object": "chat.completion", "created": 1746484762, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug with a carboxylic acid on a naphthalene core is Naproxen, whose \u2013COOH group can serve as both hydrogen bond donor (via its \u2013OH) and acceptor (via its C=O) when interacting with hydroxychloroquine\u2019s quinoline and amine functionalities.  \nANSWER: Naproxen", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 331, "completion_tokens": 412, "total_tokens": 743, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8a79a48190bf1c8da825cff4da", "custom_id": "Citalopram-Fenofibrate_0:upper_bound", "response": {"status_code": 200, "request_id": "06b84b04d16f4091ec0242ef8dedb33a", "body": {"id": "chatcmpl-BTyl84OmmTFZskhUWBnXp2nMwgPVr", "object": "chat.completion", "created": 1746484770, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Fibrates (e.g., fenofibrate) are known to reduce hepatic cholesterol 7\u03b1-hydroxylase activity, leading to cholesterol supersaturation of bile, gallstone formation, and cholecystitis. The provided interaction triple (Citalopram\u2013cholecystitis\u2013Fenofibrate) specifically implicates fenofibrate in increased cholecystitis risk when used alongside citalopram.  \nANSWER: Fenofibrate", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 808, "completion_tokens": 692, "total_tokens": 1500, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 576, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8a966881909cc906487e5031bd", "custom_id": "Telmisartan-Cinacalcet_0:upper_bound", "response": {"status_code": 200, "request_id": "6d58c6a91910c5c3098d599e24f21e38", "body": {"id": "chatcmpl-BTylMFwrXOj6nPVtFzDuxbPrp0hr6", "object": "chat.completion", "created": 1746484784, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple \u201cTelmisartan-dysarthria-Cinacalcet\u201d indicates that telmisartan is the agent linked to dysarthria when coadministered with cinacalcet.  \nANSWER: Telmisartan", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 642, "completion_tokens": 262, "total_tokens": 904, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8ab7ac8190835718bd196a478d", "custom_id": "Rofecoxib-Torasemide_3:upper_bound", "response": {"status_code": 200, "request_id": "a7d49772e1c70efd0cf25a79c5396c5e", "body": {"id": "chatcmpl-BTylUPJapnaxswZ3C4QiY0g5QNJMt", "object": "chat.completion", "created": 1746484792, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Rofecoxib is a furanone lactone with only carbonyl and sulfone oxygens (no N\u2013H), so it cannot donate H-bonds. Torasemide contains NH groups in its sulfonamide and amide moieties, so it can act as a hydrogen bond donor.  \nANSWER: Torasemide", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 366, "completion_tokens": 475, "total_tokens": 841, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8aeed48190896ce15ca947e624", "custom_id": "Lamotrigine-Dexpramipexole_3:upper_bound", "response": {"status_code": 200, "request_id": "513eb0d20f9fc8800709991fb47a03fb", "body": {"id": "chatcmpl-BTylifu1fy2BfDrvPx2nG1qpRRZ27", "object": "chat.completion", "created": 1746484806, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Lamotrigine bears two exocyclic \u2013NH\u2082 groups on its triazine core (in addition to ring nitrogens) and thus presents multiple N\u2013H hydrogen\u2010bond donor sites. Although dexpramipexole has a primary amine, lamotrigine\u2019s diamine scaffold is the more prolific H-bond donor in the Lamotrigine\u2013Dexpramipexole interaction.  \nANSWER: Lamotrigine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 344, "completion_tokens": 1778, "total_tokens": 2122, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1664, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8b088c8190b58ec466f7089ce5", "custom_id": "Alprazolam-Doxazosin_0:upper_bound", "response": {"status_code": 200, "request_id": "d642b48ca5e8685c354ad164ab7785b2", "body": {"id": "chatcmpl-BTymIuEsmGMcTBhLNtnTWhchfcHuL", "object": "chat.completion", "created": 1746484842, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple specifies \u201cAlprazolam-myelodysplasia-Doxazosin.\u201d Doxazosin is the selective \u03b11-adrenergic blocker used for benign prostatic hyperplasia and hypertension, and the other drug in this pair is the potent anxiolytic targeting the GABA_A receptor chloride channel. That drug is Alprazolam.  \nANSWER: Alprazolam", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 688, "completion_tokens": 359, "total_tokens": 1047, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8b29c481909f6aaf9a620801cd", "custom_id": "Ciclopirox-hydroxychloroquine_0:upper_bound", "response": {"status_code": 200, "request_id": "dff073f28bc0d9aac17d6e1a4ac51fcc", "body": {"id": "chatcmpl-BTymOUZqe5jiMBRePaMBekfvY1XST", "object": "chat.completion", "created": 1746484848, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug described\u2014used for malaria prophylaxis and autoimmune conditions such as lupus erythematosus\u2014is hydroxychloroquine. In the provided interaction triple (Ciclopirox\u2013Adenopathy\u2013hydroxychloroquine), hydroxychloroquine is linked to the risk of adenopathy when coadministered with the topical antifungal ciclopirox.  \nANSWER: hydroxychloroquine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 598, "completion_tokens": 231, "total_tokens": 829, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 128, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8b43dc8190a841879d19a93e7b", "custom_id": "alendronic acid-Ibuprofen_3:upper_bound", "response": {"status_code": 200, "request_id": "2a904cbd92efbbb62c3a08444b380455", "body": {"id": "chatcmpl-BTymU1ylgJHRdoztYIDEvhsnufvDu", "object": "chat.completion", "created": 1746484854, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug with two phosphonic acid groups each bearing hydroxyl substituents is alendronic acid, and it forms hydrogen bonds with the carboxylic acid group on the isobutylbenzene core of ibuprofen.  \nANSWER: alendronic acid", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 315, "completion_tokens": 268, "total_tokens": 583, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8b5e708190ac2460a7488aed4e", "custom_id": "Celecoxib-Labetalol-Metoprolol-Gastrin-releasing peptide receptor_8:upper_bound", "response": {"status_code": 200, "request_id": "a1e1f34993b75105900428103c52d7ab", "body": {"id": "chatcmpl-BTymZ4z641wlb4EinTNmg8xcRJdLN", "object": "chat.completion", "created": 1746484859, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The drug\u2013protein interaction data indicate that metoprolol directly binds to and activates the gastrin\u2010releasing peptide receptor, which is highly expressed in the pancreas and regulates gastrointestinal hormone release and epithelial cell proliferation.  \nANSWER: Gastrin\u2010releasing peptide receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1315, "completion_tokens": 267, "total_tokens": 1582, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8b77a08190acfd962b25a4587a", "custom_id": "Duloxetine-Darunavir_0:upper_bound", "response": {"status_code": 200, "request_id": "db1999caafd24fc5d40099240842b234", "body": {"id": "chatcmpl-BTymc2AcqBZkrdT18UkbT3PJigaEQ", "object": "chat.completion", "created": 1746484862, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The interaction triple identifies duloxetine co-administered with the boosted protease inhibitor darunavir as being linked to an increased risk of narcolepsy.  \nANSWER: Duloxetine", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 713, "completion_tokens": 251, "total_tokens": 964, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8b91fc81908063b3cc2316f49b", "custom_id": "Minoxidil-Perindopril_3:upper_bound", "response": {"status_code": 200, "request_id": "5c47baa0ba2918a8e99f614a976e6e8d", "body": {"id": "chatcmpl-BTymgE21roEBqJJzijdGgZCgKmpUq", "object": "chat.completion", "created": 1746484866, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Perindopril\u2019s multiple carboxylic acid and ester groups present carbonyl oxygens (and, under physiological pH, carboxylate oxygens) that are far stronger hydrogen-bond acceptors than the mainly NH/OH donors on the aminopyrimidinone/piperidine system of Minoxidil.  \nANSWER: Perindopril", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 355, "completion_tokens": 543, "total_tokens": 898, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8bc5c081909770f15c4d5d2851", "custom_id": "Oxaprozin-Sildenafil_3:upper_bound", "response": {"status_code": 200, "request_id": "5fb296ccf345133b7d6ed071134dddd4", "body": {"id": "chatcmpl-BTyjOaUGDbAM8NYm9UX2v3l8VMHfX", "object": "chat.completion", "created": 1746484662, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The fused benzoxazole core with a propionic acid side chain and biaryl framework describes Oxaprozin. This compound is reported to engage in a \u03c0-\u03c0 stacking interaction with a molecule featuring a pyrazolopyrimidinone scaffold and a sulfonamide-substituted piperazine ring (Sildenafil).  \nANSWER: Oxaprozin", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 361, "completion_tokens": 541, "total_tokens": 902, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8be7748190a2391b6026e6407f", "custom_id": "Ibuprofen-Repaglinide_3:upper_bound", "response": {"status_code": 200, "request_id": "2a2cdf3965172fc9c75d4b54cc7c943b", "body": {"id": "chatcmpl-BTyjXMa5oPrhprhbFQ920IiTK0zFR", "object": "chat.completion", "created": 1746484671, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: Ibuprofen\u2019s propionic acid moiety contains a free \u2013OH that can donate H-bonds, whereas Repaglinide\u2019s amide and carboxylate carbonyl oxygens serve as H-bond acceptors in the documented Ibuprofen\u2013Repaglinide interaction.  \nANSWER: Ibuprofen acts as the hydrogen-bond donor (Repaglinide as the acceptor)", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 353, "completion_tokens": 1253, "total_tokens": 1606, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1152, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
{"id": "batch_req_68195a8c06a88190b0450e01972005cc", "custom_id": "Trazodone-Alpha-2C adrenergic receptor_6:upper_bound", "response": {"status_code": 200, "request_id": "426f76dae1fd9764ed82eaa68f1612a0", "body": {"id": "chatcmpl-BTyjsS9rN8P2hfqllvpUX5qaaRS5Q", "object": "chat.completion", "created": 1746484692, "model": "o4-mini-2025-04-16", "choices": [{"index": 0, "message": {"role": "assistant", "content": "REASON: The question describes an orally administered phenylpiperazine antidepressant, which is trazodone, and asks which alpha-2 adrenergic receptor encoded by a human gene is inhibited upon its binding. From the provided interaction data, trazodone binds to and inhibits the alpha-2C adrenergic receptor, which is encoded by the ADRA2C gene.  \nANSWER: Alpha-2C adrenergic receptor", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 481, "completion_tokens": 300, "total_tokens": 781, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 192, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}}, "error": null}
